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Mycobacterium tuberculosis is an air borne, facultative intracellular bacterial pathogen 
that resides in the phagosome of host cells. Virulence of M. tuberculosis is related to 
its abilities to respond to environmental cues encountered during infection and 
reprogram its metabolism to adapt to them. Nutrients derived from the host are key 
factors contributing to shape the carbon metabolism of M. tuberculosis during 
infection. This metabolic shift involves activation of fatty acid and cell wall lipids 
metabolism of the bacterium; however, the mechanistic interplay between them is 
undefined. In this study, to understand the metabolic adaptation on propionyl-CoA 3-
carbon product of cholesterol in M. tuberculosis, the propionate detoxification and 
methyl-branched (MB) lipid synthesis pathways were investigated. The data presented 
here shows that excess propionyl-CoA was toxic to M. tuberculosis, as the propionyl-
CoA inhibited pyruvate dehydrogenase (PDH) and acetate or fatty acid rescued the 
toxicity through providing acetyl-CoA the product of PDH. A mechanistic insight was 
revealed by metabolic labeling with radioactive propionate and fatty acids: the given 
fatty acids facilitate propionyl-CoA incorporation into a key MB lipid PDIM by 
serving as acyl-primers required for its biosynthesis. Additionally, to further define 
genes required for propionate and fatty acid metabolism an approach exploiting 
propionate toxicity and TraSH analysis was employed. The data from the genetic 
  
profiling by TraSH confirms our model for the fatty acids rescue from the propionate 
toxicity and suggests putative roles for uncharacterized genes in MB lipids synthesis 
and fatty acid metabolism. This model was also validated by using lipid droplet loaded 
macrophage where M. tuberculosis exploited fatty acids from the host lipid droplet to 
synthesis PDIM resulting in reduction of the propionate stress. Data presented in this 
work demonstrates that the propionyl-CoA processing is a significant problem for 
survival in the host cell, and that the routing of propionyl-CoA into MB cell wall 
lipids plays an important role for limiting the metabolic stress derived from 
propionate. And, the data also demonstrates that the fatty acids from lipid droplets in 
the host macrophage may provide a well-balanced diet that retains appropriate level of 
acetyl-CoA and propionyl-CoA. 
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CHAPTER ONE  
Introduction 
1.1 History of tuberculosis 
          Tuberculosis has plagued human beings throughout human known history and 
prehistory. Skeletal analysis suggests that TB was present in Africa as early as 50,000 
years ago. Archeological evidences for TB, including Pott`s deformities found in 
Egyptian mummies, can be documented more than 5,000 years ago. Just as in Egypt, 
evidence for various manifestation of TB are also found in America and all across 
Europe throughout the human history [1-4]. Written documentation of patients with 
TB-like symptoms first appeared in the seventh century B.C [5]. By the early of 19th 
century, TB was devastating European countries claiming close to 1,000 lives per 
million people annually. Throughout the centuries, scientists and medical practitioners 
had sought to understand the origin of TB. In 1865, a French physician, Jean-Antoine 
Villemin demonstrated the contagious nature of TB by showing transmission of TB to 
laboratory rabbits from tuberculosis tissue from a patient who died of tuberculosis. 20 
years later, in 1882, Robert Koch changed the history of tuberculosis through his 
identification of Mycobacterium tuberculosis as the causative agent of TB, and the 
development of a standardized set of parameters required for the identification of the 
causative agent of all infectious diseases (Koch-Henle postulates) [6]. 
          Over 130 years later, despite efforts, TB is still one of the deadliest infectious 
diseases; one-third of the world population is latently infected with M. tuberculosis 
and 1.8 million people die annually from TB, including 0.5 million deaths in 
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individuals co-infected with human immunodeficiency virus (HIV) (WHO). The 
emergence of drug resistant strains and HIV associated tuberculosis has complicated 
the current tuberculosis pandemic [7]. Although our current chemotherapy is effective 
for the control of TB, it is hampered by the vast reservoir of latently infected people 
and frequent non-compliance in anti-mycobacterial therapy, which is associated with 
the development of drug resistant strains. Thus, understanding of the M. tuberculosis 
physiology underlying survival of M. tuberculosis both inside and outside the host is 
central to design of more effective drugs. 
 
1.2 M. tuberculosis, the bacillus   
          M. tuberculosis is a gram positive, rod shaped bacillus in the family 
Mycobacteriaceae. It comes from the genus Mycobacterium, which is composed of 
close to 100 recognized species [8]. Although most of bacteria in the genus 
Mycobacterium are non-pathogenic, M. tuberculosis is a well adapted human pathogen 
and, along with M. africanum, M. canettii, M. bovis, and M. microti, it comprises the 
M. tuberculosis complex (MTBC) [9]. 
          M. tuberculosis has complex lipid-loaded cell wall containing unique, long 
chain mycolic acid that is responsible for formation of acid-stable complexes when the 
carbol fushin dyes are added (acid fast). It is believed that this complex lipid coat 
forms a gram negative like outer membrane [10] (Figure 1.1B). M. tuberculosis is a 
slow growing bacteria with 16-24 hour generation time and is highly aerobic and 
requires high levels of oxygen. Its genome is distinguished by 65.5% G+ C rich and 
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contains approximately 4,000 open reading frames (ORF), with hypothetical functions 
annotated for over 40% of these genes [11]. Classical virulence factors, such as type 
III effector proteins, are missing in the M. tuberculosis genome. However, its genome 
contains 250 genes (8% of its genome) involved in fatty acid metabolism, with 39 of 
these involved in the polyketide metabolism generating the extremely hydrophobic 
coat [11]. Such large numbers of genes show the evolutionary importance of the lipid 
coat to its survival in the host. Indeed, the lipid coat provides a hydrophobic barrier to 
antibiotics [12], and the biosynthetic pathway of such lipids has been targeted by anti-
mycobacterial drugs as shown by the mode of action of isoniazid on inhA of mycolic 
acid biosynthesis [13].  
          M. tuberculosis is characterized by a range of complex lipids based on 
multimethyl-branched fatty acids (Figure 1.1A). These lipids include the 
dimycocerosates of the phthiocerol family (PDIMs), a family of sulfated acyl-
trehaloses (SL), diacyl trehalose (DAT), and a heavily acylated trehalose, pentaacyl 
trehalose (PAT) [14, 15]. These methyl-branched lipids build a characteristic M. 
tuberculosis outer membrane by interaction with the monolayer of mycolic acids [16].  
Other members of the mycobacteria appear to have alternative characteristic 
dimycocerosates of glycolipids: M. bovis BCG, M. microti, and M. marinum produce a 
phenolic glycolipid [17], mycoside B [18], and lipooligosaccharides  (LOS) [19], 
respectively. The biosynthesis of these multimethyl-branched lipids involves 
processing and elongation of fatty acid acyl-chains by over 20 pks genes in M. 
tuberculosis [15]. Because theses lipids are believed to be key virulence factors, their 
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regulations and carbon metabolism involved in their biosynthetic pathways have been 
studied extensively over the last few decades [20].  
 
1.3 Tuberculosis and current drug regimens 
           When humans are exposed to M. tuberculosis, 5-10% develop progressive 
disease, which is characterized by weight loss, fibrosis and persistent coughing. The 
majority of remaining infected individuals (~90%) develop a latent infection, with no 
apparent clinical symptoms for decades [21]. Although latently infected people are 
non-infectious and resistant to re-infection on repeated exposure, these constitute a 
large reservoir of potential infections. Among these latent infections, there is a ~5% 
risk of developing active disease during the remaining life time [22]. However, the 
risk of reactivation of latent infection increases significantly with HIV co-infection or 
in an immunocompromised condition.  Approximately 13% of active tuberculosis is 
related to co-infection with HIV [23]. 
          Current anti-tuberculosis vaccine was developed in the 1930s by using an 
attenuated M. bovis Bacillus Camette-Guerin (BCG) strain [24]. While the BCG 
vaccine provides partial protection against disseminated forms of TB during early 
childhood, it has limited efficacy in preventing tuberculosis in adult; on the basis of 
controlled clinical trial, an overall protective effect in adult is approximately 50% [25, 
26]. Nevertheless, currently it is the most widely used vaccine; it continues to be 
administered in infants in countries where TB is endemic [27].   
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Figure 1.1  M. tuberculosis cell wall   (A) components in the cell envelope [15].  the 
PDIMs, dimycocerosates of the phthiocerol family; SL, sulfated acyl-trehaloses; DAT, 
diacyl trehalose; PAT, pentaacyl trehalose; mAG, mycolyl ararbinogalactanp; PG, 
peptidoglycan; LAM, lipoarabinomannan; PIM, phophatidylinositol pentamannoside.  
(B) double layer of the cell envelope[10].  
 
A 
B 
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To replace BCG, more than 30 candidate vaccines are under development, some of 
them showed close to 40% efficacy for prevention of TB in HIV-infected adults [21].   
          Because of the limited protection of BCG vaccine, the main TB treatment relies 
on chemotherapy. For patients with active pulmonary tuberculosis, current standard 
drug treatment regimens include four first-line drugs, isoniazid, rifampin, 
pyrazinamide, and ethambutol. Treatment requires at least 6 months [28]. People with 
latent M. tuberculosis infection also require preventive drug treatment; the current 
recommended regimen is isoniazid alone administrated for 9 months. With early 
diagnosis and administration of effective regimens, the current treatment achieves 
more than 95% cure rate [22]. However, the treatment is compromised by the 
emergence of multidrug-resistant M. tuberculosis (MDR-TB). In 2012 alone, 440,000 
new cases of TB were estimated globally [23]. Patients infected with the MDR-TB are 
treated with second-line drugs or combination regimens of these and first-line drugs 
for 20-30 months (WHO guideline). These second–line drugs include fluoroquinolone, 
ethionamide, cycloserine, and para-aminosalicylic acid [29]. However, the second-line 
drugs are highly toxic and are not well-tolerated, rendering treatment difficult. 
Moreover, the recent emergence of extensively drug resistant strains of M. 
tuberculosis (XDR-TB), which is resistant to isoniazid, rifampin, and even second-line 
drugs, increases the threat to current TB control. Therefore, there is an urgent need to 
find new strategies to combat M. tuberculosis. 
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Figure 1.2 Electron micrograph of a human alveolar macrophage infected with M. 
tuberculosis [30]  
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1.4 M. tuberculosis pathogenesis  
1.4.1 Overview 
          TB infection is initiated when M. tuberculosis, inhaled as aerosol droplets, are 
engulfed by alveolar macrophages mainly (Figure 1.2), but it is also possible that the 
bacilli can be ingested by alveolar epithelial pneumocytes or dendritic cells in the lung 
[31, 32]. Following phagocytosis, the infected host cells recruit monocytes, 
lymphocytes, and neutrophils from neighboring blood vessel through a 
proinflammatory response that is highly dependent on the production of tumor 
necrosis factor (TNF) by infected macrophage [4, 31]. These cells form the early 
granuloma, which is the pathogenic feature of tuberculosis: the granulomas are 
composed of infected macrophages surrounded by macrophage-derived giant cells, 
foamy macrophages, epithelioid macrophages and lymphocytes [33-36]. Through this 
process, containment of M. tuberculosis, host is achieved, which blocks the spread of 
the bacteria. This contained infection is referred as latent tuberculosis, in which the 
host stays asymptomatic and in a non-transmissible state until the host immune state 
changes. When host immunity is compromised by immunosuppressive conditions such 
as HIV co-infection, the center of the granulomas become caseous, and necrotic. 
Following such a change the bacteria become reactivated and are thought to replicate 
in the liquefied center of granuloma. Then, these granulomas release the reactivated, 
infectious bacilli into the airways or blood vessel, which allow M. tuberculosis to 
escape from ‘the containment’ and spread to neighboring lung tissue and even to other 
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organs. This state is referred to as active pulmonary tuberculosis and represent the 
transmission stage of the infection [31].  
 
1.4.2 Host immune response  
          During the early innate immune response, the phagocytes initiate internalization 
of M. tuberculosis through the recognition of components of the bacilli. These host 
receptors include toll-like receptors (TLR) 2, TLR4, and phagocytic receptors such as 
C-type lectin receptors, the mannose receptors, and DC-SIGN [37-42]. In addition to 
membrane bound receptors, the cytosolic recognition receptors, NOD2 [43] and 
NLRP3 [44] also recognize mycobacterial peptidoglycan  and secreted protein ESAT-
6 respectively [45]. Following recognition the infected cells employ anti-microbial 
strategies to limit the growth of M. tuberculosis, including acidification of phagosome, 
autophagy [46, 47], and apoptosis [48]. But, M. tuberculosis has evolved multiple 
mechanisms to survive within the host cells.  M. tuberculosis modulates the trafficking 
and maturation of its phagosome, allowing it to avoid the hostile environment of the 
lysosome. This is accomplished by preventing the recruitment of the vacuolar ATPase 
and maintaining a pH of 6.4 within its phagosome [49]. As such, the phagosome 
containing M. tuberculosis appears to be arrested at an early stage of its maturation. 
Several mycobacterial effectors have been implicated in this inhibition of phagosome 
maturation: (1) the bacterial lipids: lipoarabinomannan [50-52], trehalose dimycolate 
[53-56], and the sulfolipids[57], (2) the bacterial proteins: secreted acid phosphatase 
(sapM) [58], Zinc metalloprotease (zmp1) [59] and protein kinase G (pknG) [60].  
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Also, by regulating apoptotic and necrotic cell death, M. tuberculosis can generate a 
productive cellular niche; inhibiting host cell apoptosis allows for expansion of 
bacterial population in a single cell, but also for prolonged survival of infected cells 
before the cell dies [61-63]. Cell death does appear to be a bacteria-driven 
phenomenon and ESX1 induces the necrotic death of infected macrophage and the 
recruitment of other macrophages to serve as new host cells [64].  
          In the early stages of granuloma formation, inflammatory cytokines, TNF and 
INF-are primary mediators of cellular immune response [65-68]. These cytokines are 
required to control M. tuberculosis infection and for the formation of organized 
granuloma, which is impaired in TNF or INF- deficient mice [66, 68]. Activation of 
the infected host cells with INF- leads extensive changes in the intracellular 
environment: delivering the bacilli into lysosomes through the acidification of 
bacterium containing phagosome (to pH5.2) [69], oxidative killing through reactive 
nitrogen and oxygen intermediates [70].  Primarily, these cytokines are produced by T 
cells. As such, it is believed that the M. tuberculosis infection is controlled by a 
variety of T cells, including CD4, CD8, and CD1 T cells [71, 72]. Following infection, 
the activation of M. tuberculosis specific CD4 T cells is observed prior to stimulation 
of CD8 T cells. CD4 T cells recognizes mycobacterial protein (or peptide) antigens 
presented in antigen presenting cells (APC), and produces high levels of INF- which 
in turn activates infected macrophages [73]. This observation is validated by the 
finding that HIV patients with the depleted CD4 T cells were susceptible to 
tuberculosis [74]. In addition to CD1 T cells, both CD8 T cells and CD1 restricted T 
cells also contribute to controlling M. tuberculosis infection through INF- production 
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and cytolytic activity [75-78]. CD1 restricted T cells recognize non-peptide antigens 
such as lipid and glycolipid antigens presented in CD1 molecules [79, 80].     
 
1.5 Intracellular environment and adaptation  
          Despite the fact that M. tuberculosis arrests normal phagosomal maturation and 
resides in a compartment that resembles an early endosome [81, 82], the intracellular 
environment of the macrophage phagosome is still hostile. Moreover, activation of the 
infected macrophage or induction of autophagy in the cells leads to phagosome 
maturation, resulting in delivery of M. tuberculosis containing vacuole to an acidic, 
hydrolytically competent lysosome. In addition to this acidification, during infection, 
M. tuberculosis can encounter other anti-microbial strategies of the host, including an 
increase in reactive oxygen and nitrogen intermediates, excess metal ions, and 
antimicrobial peptides. M. tuberculosis has however evolved to adapt and exploit this 
hostile environment.  
 
1.5.1 Acidification of the phagosome  
          Among these intracellular challenges generated by host, it appears that 
phagosomal acidification is a central cue to M. tuberculosis. During the infection, the 
bacterium resides in a phagosome with around pH 6.4, which drops close to pH 5.2 as 
the phagosome matures in the activated macrophage. Indeed, M. tuberculosis’s 
responses to this pH shift were revealed by transcriptional profiling; it was observed 
that 30 out of 68 genes which are induced 2 hours post-infection were related to 
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phagosomal acidification[83, 84]. Primarily, M. tuberculosis senses and responds to 
pH shift through a two-component signal transduction system, phoPR.  
          Transcriptional profiling suggests that phoPR regulates 64 genes constituting 
phoPR regulon, 44 of which are involved in lipid metabolism and the synthesis of M. 
tuberculosis cell envelope components [84]. For example, phoPR induces pks2 and 
pks3, which encodes enzymes involved in production of virulence-associated acyl-
trehaloses, such as sulfolipids, polyacyltrehalose (PAT) and diacyltrehalose (DAT). At 
low pH, a phoP mutant lacks these acyl-trehalose, but produces more phthiodiolone 
and phthiocerol A (PDIMs) [85-87]. In addition, aprA which is also regulated by phoP 
was shown to regulate expression of genes involved in PDIM biosynthesis. At low pH, 
in contrast to the phoP mutant, production of PDIMs was decreased in mutants lacking 
aprA [88].  
          Together, these suggest a link between the phoPR regulon and M. tuberculosis 
lipid metabolism in response to a pH shift indicating that M. tuberculosis uses pH to 
sense the host environment and remodel its cell wall to enhance intracellular survival.  
 
1.5.2 Toxic molecules: ROS, RNI, and metal ions  
          Phagocytes also employ diverse toxic molecules to limit the infection. These 
include ROI by the NADPH oxidase (Phox), RNI by nitrate oxidase (NOS2), and 
excess metal ions such as copper.  
          Among them, radical-mediated killing is likely the primary antimicrobial 
mechanism [89]. Indeed, mice deficient in both Phox and NOS2 are markedly 
susceptible to a variety of infections [90]. However, M. tuberculosis has evolved a 
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variety of resistance mechanisms against oxidative stresses. For example, M. 
tuberculosis maintains an antioxidant defense mechanism through a NADH-dependent 
peroxidase and peroxynitrite reductase which is constituted by dihydrolipoamide 
dehydrogenase (lpd), dihydrolipoamide succinyl-transferase (sucB), alkyl-
hydroperoxide reductase (ahpC), and ahpD. Also, mycobacterial catalase (katG) and 
superoxide dismutases (sodA and sodC) enhance tolerance to oxidative stress [91]. 
Additionally, M. tuberculosis also produces an anti-oxidant, mycothiol, which serves 
similar functions to glutathione [92, 93]. Synergistically, these series of mechanisms 
provide protection for mycobacterial proteins and DNA damage from ROI and RNI 
during infection.  
          In addition to toxic RNI and ROI, the mammalian host utilizes Cu as an 
antimicrobial agent exploiting the catalytic capacity of the metal through its redox 
chemistry: as a redox active metal, Cu reacts with H2O2, resulting in the generation of 
toxic hydroxyl radical and hydroxyl anion [94, 95]. Indeed, upon activation of the 
macrophage, Cu levels in the phagosomes containing mycobacteria increase  
dramatically [96]; the macrophage elevates  Cu concentration through a high affinity 
Cu importer (Ctr1) and ATPase Cu pump (AP7A) [97]. Cu is an essential component 
of large number of microbial enzymes involved in a wide variety of cellular process, 
such as cell growth, stress response, and survival during infection [98, 99]. However, 
excess Cu is toxic. In order to minimize the Cu toxicity generated by host cells, M. 
tuberculosis encodes two Cu-responsive regulons known as CsoR system and RicR 
regulon [100, 101], including P-type ATPase metal transporter (ctpV) [101, 102] and 
mycobacterial cooper transporter B (mctB) [103, 104]. 
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1.5.3 Starvation 
          In addition to these toxic molecules, the hosts also employ starvation 
mechanisms to restrict the growth of M. tuberculosis. It has been demonstrated that 
activated macrophages starve the bacterium of nutrients such as amino acids, 
carbohydrates, and essential metal ions.  
          During the infection, starvation of amino acids in phagosome has been shown 
through analysis of auxotrophic strains.  Lysine, proline, leucine, and tryptophan 
auxotrophs are all attenuated in mice [105-108]. In order to efficiently replicate in an 
amino acid depleted environment M. tuberculosis has evolved to retain the 
biosynthetic pathways for 20 amino acids [11]  and independently synthesize its own 
amino acids regardless of the host environment [84, 109]. In addition to amino acid 
depletion, host cells can also deplete intracellular iron through iron sequestration for 
defense against mycobacterial infection [110]. Activated macrophages exhibit low iron 
levels within the phagosomes [111]. Since iron is an essential redox cofactor of 
enzymes required for essential cellular process, iron acquisition is important to 
maintain infection. M. tuberculosis employs sideropheres and mycobactin to compete 
for iron with host. Mycobactin is synthesized by the mbtA-N locus under iron-limited 
conditions [112]. Finally, it has long been believed that the host macrophage may 
restrict carbohydrate availability to M. tuberculosis within its phagosome. In bacterial 
cell, if exogenous glucose is limited, 6-carbon intermediate such as glucose 6-
phosphate is generated through gluconeogenesis, rendering the bacterium dependent 
on the gluconeogenesis [113]. Among enzymes involved in this de novo synthesis is 
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phosphoenolpyruvate carboxykinase (pckA) that converts oxaloacetate to 
phosphoenolpyruvate. Indeed, using bacterial transcriptional analysis, it has been 
demonstrated that the expression of pckA was elevated during mice infection and this 
result was directly validated using pckA mutant [114-116]. While M. tuberculosis is 
challenged by carbohydrate depletion during infection, it is likely that the bacterium is 
exposed to sufficient amount of host lipids and appears to shift its metabolism to 
exploit them [117].     
   
1.6 Lipid diet during M. tuberculosis infection  
1.6.1 Host tissue remodeling to support infection 
          In recent studies, the strong association of lipid loaded foamy macrophages with 
tuberculosis granulomas has been demonstrated and it is likely that the foamy cells 
provide a lipid rich micro-environment for intracellular M. tuberculosis [118, 119]. 
Using electron microscopy, several groups have shown that, in foamy macrophages, 
phagosomes containing M. tuberculosis are tightly apposed to lipid bodies, which 
suggests that the bacterium may have access to host lipids and metabolize them [119] 
(Figure 1.3). The induction of these lipid droplets in macrophages has been observed 
in many bacterial or viral infections [118]. Primarily, in infection, lipid bodies in the 
cells are accumulated through the activation of toll like receptors and proinflamatory 
cytokines. Macrophages can also induce lipid bodies to store lipids when they are 
exposed to a high concentration of fatty acids or lipoproteins such as low-density 
lipoproteins (LDLs) [120].  Dysregulation of LDL processing through genes involved 
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in cholesterol efflux, was shown to lead to accumulation of lipid bodies in 
macrophages. Indeed, in M. tuberculosis infection, this was validated by the 
transcriptional profiling of human TB granulomas, which revealed a significant 
dysregulation in lipid metabolism [121].  The mycobacterial cell wall lipid TDM has 
been shown to drive the formation of foamy macrophages during infection [122]. 
Recently, macrophages were also shown to accumulate lipid bodies under hypoxic 
conditions in culture, which is thought to mirror the microaerophilic environment in 
the human TB granuloma [123-125]. 
 
1.6.2 Bacterial metabolic reprogramming 
          This lipid rich environment of the host shapes the carbon metabolism of M. 
tuberculosis. During infection, strong induction of genes involved in fatty acid 
degradation has been shown by transcriptional profiling, suggesting the preferential 
utilization of fatty acids as a carbon source [84, 117, 126-128]. These genes include 18 
genes involved in beta-oxidation of fatty acids and several genes involved in 
metabolic pathways for products of fatty acid breakdown, such as isocitrate lyase (icl) 
of the glyoxylate cycle (acetyl-CoA) and Rv1130-Rv1131 of methylcitrate cycle   
(propionyl-CoA) [129]. This theme has been observed in several independent studies. 
Perhaps, this metabolic shift to a lipid-based diet is due to availability of host lipids 
surrounding M. tuberculosis during infection. This is consistent with the early 
observation that the bacterium from infected mice preferentially utilizes fatty acids 
over carbohydrates [130]. Because of this host lipid environment, M. tuberculosis 
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appears to have become enriched for genes involved in fatty acid metabolism [11]. 
Many of these genes play important roles in metabolic and cell wall envelop 
remodeling, which are required for survival in host cells. For example, isocitrate lyase 
is required for survival in macrophage and mice [131, 132]. The glyoxylate cycle 
gated by the isocitrate lyase is a variation of the tricarboxylic acid cycle, and as an 
anabolic pathway (conversion of acetyl-CoA to succinate), allows the bacterium to 
utilize carbon source generating acetyl-CoA [133]. Since fatty acids breakdown 
through -oxidation yield acetyl-CoA, the glyoxylate cycle is indispensable in a fatty 
acid based growth condition.   
 
1.7 M. tuberculosis and propionate  
1.7.1 Cholesterol during infection 
          Mass spectrometric analysis of the lipids present in the caseum from human 
tuberculosis granulomas revealed the major lipid contents, including triacylglycerol, 
cholesterol, and cholesterol ester [121]. Among these abundant lipids, cholesterol in 
particular has been thought to be an important carbon source for intracellular M. 
tuberculosis. Mutants defective in cholesterol transporter (mce4) exhibited reduced 
virulence in INF- activated and in the chronic phase of murine infection [116, 134]. 
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Figure 1.3 M. tuberculosis containing phagosomes in contact with lipid bodies in 
foamy macrophages[36] 
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Moreover, this phenotype of mce4 mutant is very similar to the phenotype of icl 
mutants [131, 132]. This is significant because in M. tuberculosis isocitrate lyase plays 
a role in the methylcitrate cycle, which is an essential pathway to reduce the toxicity 
of propionyl-CoA produded during the breakdown of cholesterol by the bacterium.  
Together, the phenotypes of the mutant icl or mce4 suggest that M. tuberculosis is 
exposed to host-derived cholesterol and the bacterium utilizes it as carbon source 
during infection. 
 
1.7.2 Propionate metabolism during infection  
          In addition to cholesterol, propionyl-CoA can be also generated by -oxidation 
of odd (or branched) chain fatty acids and catabolism of branched chain amino acids 
such as valine [135]. During infection, M. tuberculosis appears to become exposed to 
a significant concentration of propionyl-CoA [136]. Propionate, the 3 carbon fatty acid, 
has long been used as antimicrobial and antifungal agent because of its growth 
inhibitory effects [137] and there are several studies into its mechanisms of the 
toxicity [138-140]. However, despite the importance of propionate metabolism in 
mycobacteria, the targets of the propionyl-CoA or mechanisms of its toxicity have yet 
to be revealed.  
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Figure 1.4 Pathway for lipid metabolism in M. tuberculosis [141] 
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          In M. tuberculosis, three biochemical pathways have been proposed to facilitate 
propionyl-CoA metabolism: the methylcitrate cycle, the methylmalonyl pathway, and 
the biosynthesis of methyl-branched polyketides such as PDIM, PAT, and SL-1 
(Figure 1.4).  The latter pathways in particular, have been implicated in virulence of M. 
tuberculosis. Propionyl-CoA carboxylase in the methyl-malonyl pathways converts 
propionyl-CoA to methyl-malonyl-CoA, which can be fed into biosynthetic pathways 
of methyl-branched polyketides [15]. Since polyketides are produced by iterative 
condensation of acetyl-CoA (or longer acyl-CoA) and methyl-malonyl-CoA, the 
balance between the 2 carbon units (acetyl-CoA) and 3 carbon units (propionyl-CoA) 
is likely critical to their synthesis. This connection between propionate metabolism 
and polyketide biosynthesis has been demonstrated by the elevated production of 
PDIMs or SL-1 of M. tuberculosis grown on propionate [142]. In addition to this 
direct link, propionate metabolism is also connected to polyketide metabolism through 
the transcriptional regulator whiB3, which senses redox changes in the bacterial 
cytosol and regulates the biosynthesis of cell wall lipids including the methyl branched 
polyketides and triacylglycerol [143]. A mutant defective in whiB3 exhibited 
resistance to elevated levels of propionate and had enhanced levels of PDIMs in vitro. 
This is significant because, whiB3 seems to help M. tuberculosis to deal with 
metabolic stresses such as propionate toxicity and redox imbalance through the 
elevation of -oxidation upon metabolic shift to lipid based carbon source. These data 
demonstrate the importance of propionate metabolism in adaptation to host lipid-
derived carbon sources. However, these connections need to be validated through 
genome wide approaches to evaluate the contribution of the different metabolic 
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pathways to propionate detoxification and methyl-branched polyketide synthesis in M. 
tuberculosis.   
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1. 8 Aims of this study 
The purpose of the following work is to understand carbon metabolism in M. 
tuberculosis 
I. Understand the metabolic stress induced by propionyl-CoA 
 
II. Identify the entire set of M. tuberculosis genes required for propionate 
metabolism 
 
III. Understand the metabolic adaptations to handle excess propionate 
 
IV. Use a macrophage infection model to understand the coupled metabolic 
reprogramming in M. tuberculosis and its host cell. 
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CHAPTER TWO 
Evaluation of propionate toxicity and detoxification in M. tuberculosis 
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ABSTRACT 
Recent data indicate that the nutrients available to Mycobacterium tuberculosis  inside 
its host cell are restricted in their diversity.   Fatty acids and cholesterol appear more 
favored, however, their degradation can result in certain metabolic stresses.  Their 
breakdown can generate propionyl-CoA, which gives rise to potentially toxic 
intermediates. Detoxification of propionyl-CoA relies on the activity of the 
methylcitrate cycle, the methylmalonyl pathway or incorporation of the propionyl-
CoA into methyl-branched lipids in the cell wall. The current article explores carbon 
flux through these pathways, focusing primarily on those pathways responsible for the 
incorporation of propionyl-CoA into virulence-associated cell wall lipids.  Exploiting 
both genetic and biochemical rescue we demonstrate that these metabolic pressures are 
experienced by M. tuberculosis inside its host macrophage, and that the bacterium 
accesses host fatty acid stores to alleviate the pressure.  These data have major 
implications to our appreciation of central metabolism of M. tuberculosis during the 
course of infection.     
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2.1 Introduction 
          Mycobacterium tuberculosis, a facultative intracellular pathogen, is an 
intracellular pathogen. Most like other invasive pathogens, M. tuberculosis must 
acquire host derived nutrients and adapt metabolically to the conditions that are 
provided by the host over the course of infection. There is a growing body of literature 
indicating that M. tuberculosis utilizes a restricted set of host-derived nutrients to 
persist within its host cell. Most notably, host lipids appear to be the primary carbon 
source for M. tuberculosis in vivo or in infected macrophages in culture. The reliance 
on host-derived nutrients such as cholesterol as a major carbon source comes at a cost 
to M. tuberculosis.  In addition to the degradation of the A, B, C, and D, rings of 
cholesterol, the acyl side chain is predicted to be degraded by rounds of -oxidation, 
which will give rise to propionyl-CoA [1-3]. M. tuberculosis is exquisitely sensitive to 
increases in the propionyl-CoA pool and the bacterium has three different means of 
metabolizing this precursor of potentially-toxic metabolite(s) [4-6].  ICL1 functions 
both as an isocitrate lyase in the glyoxylate shunt as well as a methylisocitrate lyase 
that catalyzes the last reaction of the methylcitrate cycle (MCC), which converts 
propionyl-CoA to succinate and pyruvate that feeds into the TCA cycle [4, 7].  
Alternatively, propionyl-CoA carboxylase can generate methylmalonyl-CoA that can 
enter the vitamin B12-dependent, methylmalonyl pathway (MMP) leading to the 
production of succinyl-CoA [5].  Finally, and of considerable significance to infection, 
these 3-carbon intermediates in the form of methyl-malonyl-CoA may be used as 
building blocks for the bacterium’s cell wall lipids [8-10].  The complex lipids of the 
M. tuberculosis cell wall form an impressive hydrophobic barrier around the 
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bacterium and are also known modulators of host cell function, acting as highly potent 
virulence factors [11].  These bioactive lipids can be esterified with up-to five multiple 
methyl-branched (MB) long chain fatty acids, which provides an effective “sink” for 
excess propionyl-CoA. In M. tuberculosis, these MB lipids include the phthiocerol 
dimycocerosates (PDIM), and the trehalose ester families including sulfolipid-1 (SL-
1), diacyltrehalose (DAT), triacyltrehaose (TAT), and polyacyltrehalose (PAT) [12]. 
These M. tuberculosis-lipids are synthesized by individual polyketide synthase 
complexes from malonyl- and methylmalonyl–CoA (MM-CoA), which originate from 
acetyl-CoA and propionyl-CoA, respectively.  Thus, the 3-carbon metabolite 
propionyl-CoA, plays a significant role in the generation of cell wall lipids known to 
be required for the modulation of the host at both the level of the host cell and the 
infected tissue [13-18]. 
          Cholesterol is the best characterized source of 3-carbon metabolites in M. 
tuberculosis. Additionally, degradation of uneven chain length fatty acids or MB- 
amino acids will all generate propionyl-CoA, therefore the interplay between the 
assimilatory pathways (MCC and MMP) and the biosynthetic incorporation of MM-
CoA into MB-cell wall lipids is critical to minimizing the potential toxicity of these 
metabolites while maximizing their “usefulness” for either energy production or 
building blocks for the bacterium’s cell wall lipids.  In this current study we 
selectively manipulated carbon flux through the three different propionyl-CoA 
processing pathways to elucidate both the genetic and biochemical linkages between 
the pathways, as well as the factors that promote incorporation of 3-carbon 
intermediates into the cell wall lipids of the bacterium.  Moreover, we demonstrate 
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through biochemical rescue, that M. tuberculosis can access and metabolize the lipid 
stores in its host cell to shunt propionyl-CoA through favored, non-intoxicating routes 
of degradation or synthesis.  
 
2.2 Materials and Methods 
Culture media and Growth conditions 
M. tuberculosis strains were maintained in Middlebrook 7H9 medium supplemented 
with 0.2% glycerol, 10% OADC and 0.05% tyloxapol. Kanamycin (20 g/ml) or 
hygromycin (50 g/ml) were used where necessary. For growth on defined carbon 
sources, strains were grown without shaking in minimal medium (0.5 g/L asparagine, 
1.0 g/L KH2PO4, 2.5 g/L Na2HPO4, 50 mg/L ferric ammonium citrate, 0.5 g/L 
MgSO4,7H2O, 0.5 mg/L CaCl2 and 0.1 mg/L ZnSO4, 10 mM glycerol, and  0.05% 
tyloxapol) [19] containing propionate or fatty acids (Sigma). Prior to addition, fatty 
acids having longer chain length than butyric acid (C4) were dissolved to 100 mM in a 
solution of tyloxapol:ethanol (1:1) at 80°C for at least 30 minutes. To overcome the 
poor solubility of long chain fatty acids (C10-C24), a prewarmed 100 mM stock 
solution of each long chain fatty acids was added to the medium to a final 
concentration of 0.05 mM. To activate the MMP, VitB12 was added to a concentration 
of 10 g/ml. All chemicals were purchased from Sigma unless otherwise stated. 
 
Growth curve 
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Mycobacterial cultures of strains grown in the minimal medium were subcultured in 
1:100(v/v) in triplicate into 15ml of minimal medium with appropriate supplements. 
Cultures were incubated in T25 at 37°C without shaking, and the growth was 
monitored by measuring optical density at 600 nm (Bio-Rad) 
 
Pyruvate Quantification  
For pyruvate quantification, the medium from 100ml cultures of the Δicl1 mutant at 
OD600=1.0 was concentrated to OD600=10, and released pyruvate was quantified using 
a pyruvate quantification kit (SIGMA).   
 
Enzyme Assay 
Pyruvate dehydrogenase(PDH) was measured as described previously [20, 21]. The 
assay contained pH8.0 50mM Tris-HCl, 2.5mM cysteine, 2mM NAD, 2mM MgCl2, 
0.8mM thiamine pyrophosphate, 2mM pyruvate, and 20M CoASH in a final volume 
1 mL. The assay was started by addition of M. tuberculosis cell free lysate and 
reduction of NAD to NADH was monitored at 340 nm. 
 
 Metabolic Labeling and Lipid Analysis 
Metabolic radiolabeling of mycobacterial cell wall lipids were performed as described 
[22-24]. Briefly, bacterial strains were cultured in the 20 ml minimal medium with 4 
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Ci of [1-14C] sodium propionate, 4 Ci of [1 14C] stearic acid, or 4 Ci of [1,2-14C] 
sodium acetate for 2 weeks. Cultures were centrifuged and washed in PBS and the cell 
wall lipids were extracted twice with CHCl3/CH3OH (2:1 v/v). After determination of 
14
C incorporation by scintillation counter, 10,000 cpm from each lipid extract was 
loaded onto a TLC plate and resolved by running twice in a petroleum ether: ethyl 
acetate (98:2, v/v) solvent system. Radiolabelled lipids was detected and visualized by 
autoradiography with a phosphoimager.  
          In order to track the fate of the double-labeled stearic acid, [1-
14
C, 9, 10-
3
H] 
stearic acid (Perkin-Elmer) was used. To isolate labeled PDIM, lipid extracts were 
spotted on TLC and run twice in petroleum ether: ethyl acetate (98:2, v/v) solvent 
system. The PDIM was visualized by iodine vapor, scraped from the plates, and lipids 
were extracted in petroleum ether. The relative ratio of 
3
H and 
14
C in the isolated 
PDIM was determined by scintillation counter from 2 biological replicates analyzed in 
triplicate. 
 
2.3 RESULTS and DISCUSSION 
2.3.1 The relative, but not the absolute, abundance of 3-carbon versus 2-carbon 
metabolites is critical for M. tuberculosis fitness 
          To elucidate the pressures induced by increased concentrations of 3-carbon 
intermediates we developed approaches to experimentally modulate the concentration 
of propionyl-CoA and the bacterium’s ability to process the metabolite.  Propionyl-
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CoA, a high energy metabolite, is a key precursor to several cell wall lipids in M. 
tuberculosis [25, 26]; however, the buildup of propionyl-CoA is potentially toxic to 
the cell. Propionyl-CoA may be metabolized through either the MCC or the MMP, 
however, transcriptional profiling of M. tuberculosis in macrophages indicates that 
propionyl-CoA is metabolized predominantly through the MCC, leading to the 
production pyruvate and succinate (Figure 2.1) [27]. Additionally, the MCC genes are 
transcriptionally induced and key MCC metabolites accumulate when M. tuberculosis 
is grown in the presence of cholesterol indicating enhanced flux of propionyl-CoA  
carbons through the MCC [1]. ICL1 (Rv0467) functions as a 2-methylisocitrate lyase, 
and catalyzes that last reaction in the MCC thus, this enzymes is critical in relieving 
the potential toxicity of propionyl-CoA [28].  
          It had been shown previously that mutants defective in expression of ICL1 are 
unable to grow on propionate as a sole carbon source [7, 29].  We modified this 
approach to demonstrate that the growth of a Δicl1 mutant was normal in minimal 
medium with 10 mM glycerol but was inhibited strongly by the addition of increasing 
concentrations of propionate (Figure 2.2).  The growth of wild-type H37Rv was 
unimpaired under these conditions. This demonstrated that propionate, or its products, 
were intoxicating the Δicl1 mutant even in the presence of an alternate carbon source 
suggesting strongly that a functional MCC is critical to alleviating the increased 
propionyl-CoA concentration.  Savvi and colleagues had shown that the MMP offered  
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Figure 2.1 Propionate pathways in M. tuberculosis. Taken from Savvi et al [5]. 
 
 
 
 
50 
 
 
an alternate route for propionyl-CoA degradation but that this pathway was dependent 
on the activity of a MM-CoA synthase, which requires Vitamin B12 (VitB12) as a co-
factor [5].  Although M. tuberculosis does possess the genes required for synthesis of 
VitB12 it is likely not produced under normal in vitro culture conditions. We found 
that the addition of VitB12 to the culture medium containing the Δicl1 mutant rescued 
the mutant from propionate-mediated intoxication (Figure 2.2), thus further 
confirming the results of Saavi and colleagues, and demonstrating that both MCC and 
MMP function to detoxify propionyl-CoA rather than render it usable as an alternative 
carbon source.        
          Only acetate supplementation rescued the propionate toxicity (Figure 2.3) and, 
while we cannot formally prove that M. tuberculosis has access to all these 
intermediates, the data are consistent with the previous study on Aspergillus. Much of 
the acetyl-CoA in M. tuberculosis is generated by PDH from pyruvate and to test 
whether propionate addition impairs PDH activity we monitored the accumulation of 
extracellular pyruvate in the presence and absence of exogenous propionate in Δicl1 
mutant cultures. As hypothesized, pyruvate rapidly accumulated in the medium in the 
presence of propionate (Figure 2.4), but pyruvate was almost undetectable in the 
control culture. To further confirm this phenotype, we grew the Δicl1 mutant on 
minimal medium supplemented with 0.05 mM propionate and acetate in increasing 
concentrations from 0.5-4.0 mM, illustrated in (Figure 2.5). Interestingly, compared to 
the control culture with no propionate, the bacterial growth rates were similar when 
the acetate concentration exceeds 4 mM.  These findings indicate that propionyl-CoA,
51 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Mitigation of propionate toxicity in a Δicl1 mutant strain by acetate 
and VitB12.  The Δicl1 mutant strain of M. tuberculosis grows poorly in the presence 
of propionate but growth can be rescued by the addition of either VitB12 or acetate. 
(A)-(C) Bacterial growth, measured by absorbance at 600 nm, was determined for M. 
tuberculosis H37Rv and icl strain grown for 18 days in minimal media containing 
10mM glycerol as primary carbon source and propionate across the range from 0.02 
mM to 1 mM. Vitamin B12 at the concentration of 10 g/ml reversed the propionate 
toxicity observed in the Δicl1 mutant strain. (D) Growth at 18 day was compared. 
Data are representative of three experiments. 
 
 
A B C 
D 
H37Rv WT H37Rv icl H37Rv icl + Vit B12 
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or its products, impair the production of acetyl-CoA, and that the addition of 
increasing concentrations of acetate relieves this toxicity, which implies that it is the 
relative balance of 2- and 3-carbon intermediates that is critical for bacterial fitness.  
          To extend this observation to more physiologically-relevant substrates we 
examined the ability of longer chain fatty acids to rescue growth of the Δicl1 mutant 
in propionate containing medium [16]. We focused on even chain-length fatty acids 
because odd chain fatty acids and MB-fatty acids, would also yield propionyl-CoA 
that would elevate propionyl-CoA levels in the bacterium. First we measured the 
growth of wild-type (wt) M. tuberculosis in glycerol containing media in the presence 
of saturated even-chain fatty acids from acetic acid (C2) to lignoceric acid (C24). As 
noted previously [30, 31], free fatty acids of intermediate chain length (C10-C16) 
were toxic to M. tuberculosis but the bacterium grew well on either short or longer 
chain length fatty acids (Figure 2.6).  Next, the fatty acids that supported wt M. 
tuberculosis growth were tested for their ability to rescue the Δicl1 mutant from 
propionate-mediated toxicity.  Growth was restored to the Δicl1 mutant through 
supplementing the propionate- and glycerol-containing media with the majority of the 
fatty acids, except C12, C14, suggesting that the acetyl-CoA pool may also be 
expanded though -oxidation of long chain fatty acids (Figure 2.7). Interestingly, the 
shorter chain fatty acids (C2-C8) supplementation abrogated the propionate-mediated 
toxicity efficiently, while long chain fatty acids (C18-C24) appeared to sustain 
growth in propionate following a lag period.   
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Figure 2.3 Propionate toxicity is rescued in the Δicl1 mutant strain with acetate. 
Of the central metabolic intermediates tested only acetate (4 mM) was able to rescue 
growth of the Δicl1 mutant strain in the presence of propionate (0.05 mM). Bacterial 
growth, measured by absorbance at 600 nm, was determined for M. tuberculosis 
H37Rv and icl strain grown for 19 days in minimal media containing 10mM 
glycerol as primary carbon source supplemented with central metabolic intermediates. 
Data are representative of three experiments. 
 
A B 
C 
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Figure 2.4 Propionyl-CoA or intermediates inhibits pyruvate dehydrogenase 
(PDH). (A)-(B) pyruvate accumulates and is released from the icl1 mutant when 
grown in the presence of propionate over the course of 48 h. (C) the PDH activity of 
M. tuberculosis lysate is reduced by 60% upon addition of propionly-CoA in vitro 
assay. Data are representative of three experiments. Error bars, Standard Deviation. 
 
B C 
A 
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Figure 2.5 Acetate can rescue propionate toxicity in Δicl1 M. tuberculosis. (A) 
and (B) The C2 compound, acetate rescues propionate toxicity of Δicl1 M. 
tuberculosis in a dose dependent manner.  Bacteria were grown for 18 days in 
medium containing 10 mM glycerol (G) and 0.05 mM propionate supplemented with 
acetate across the range 0.05mM to 4mM. Bacteria were grown for 18 days in 
medium containing 10 mM glycerol and 0.05 mM propionate supplemented with a 
range of acetate. Bacterial growth was measured by absorbance at 600 nm  and results 
are representative of 3 replicates. 
 
  
B 
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Figure 2.6 Free fatty acids of intermediate chain length (C10-C16) are toxic to M. 
tuberculosis, however the bacterium utilizes fatty acids of shorter or longer chain 
length. H37Rv wild type was grown in minimal media containing 10mM glycerol 
(alternatively glucose, acetate, or succinate) primary carbon source and fatty acids 
from acetate (C2) to lignocerate (C24). Fatty acids were supplemented at 
concentration range 0.2mM – 0mM by 2-fold serial dilutions in 96 well plates. At 7 
days, bacterial growth was measured by absorbance at 600 nm and results are 
representative of 3 replicates.  
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Figure 2.7 Fatty acids of differing chain lengths rescue the Δicl1 strain from 
propionate toxicity.  Acetate, short-chain fatty acids, and long-chain fatty acids 
similar to those found in the host macrophage can rescue propionate toxicity in Δicl1 
M. tuberculosis. Short to mid-length and long chain fatty acids also rescue propionate 
toxicity in Δicl1 M. tuberculosis.  Bacteria were grown for 18 days in medium 
containing 10 mM glycerol and 0.05 mM propionate supplemented (GP) with 
saturated even-chain length fatty acids (C2-C24) at the following concentrations; 
acetate (C2) was provided with 1 mM, short chain fatty acids (C4-C8) at 0.5 mM and 
intermediate and long chain fatty acids (C10-C24) at 0.05 mM. Bacterial growth was 
measured by absorbance at 600 nm and results are representative of 3 replicates. 
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          Together, these observations support the contention that it is the relative 
abundance of 2- versus 3-carbon intermediates that plays an important role in 
protecting M. tuberculosis from the potential toxicity of propionyl-CoA.   
 
2.3.2 The methyl branched lipid, PDIM acts as a sink for propionyl-CoA 
          The third proposed route of detoxification of propionyl-CoA is through its 
incorporation into the MB-lipids of cell wall lipids. To synthesize MB-lipids, M. 
tuberculosis would require fatty acids to act as primers for the polyketide synthase-
catalyzed addition of MM-CoA from propionyl-CoA [32]. In the case of the typical 
mycocerosic acid in PDIM there is a 4:1 molar ratio of MM-CoA to acyl primer 
required for synthesis. We therefore hypothesized that under our defined growth 
conditions, the Δicl1 mutant grown in minimal medium containing propionate and 
glycerol in the absence of VitB12 is dependent upon the biosynthesis of MB-lipids as 
a means of detoxifying excess propionyl-CoA. If correct, then provision of acetate, or 
longer chain fatty acids, would facilitate synthesis of fatty acid-AMP precursors that 
would act as acceptors for methylmalonyl-CoA and enable M. tuberculosis to 
incorporate excess propionate into cell wall lipids such as PDIM.  This hypothesis 
would predict that radiolabel in the form of 
14
C in acetate, long chain fatty acids or 
propionate should all be incorporated into PDIM.  
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Figure 2.8 Fatty acids rescue propionate toxicity in M. tuberculosis through 
incorporation into methyl-branched lipids such as PDIM, in both the Δicl1 
mutant strain and wild-type M. tuberculosis. TLC analysis of the cell lipid lipids 
indicates that radiolabel derived from [1-
14
C] propionate, [1, 2-
14
C] acetate, or [1-
14
C] 
stearic acid is incorporated into the cell wall lipid PDIM. 
14
C incorporation into 
PDIM is enhanced by 0.05 mM propionate but is a constitutive process in both the 
Δicl1 mutant strain, and in the high-PDIM-producing wild-type Erdman strain. 
Bacteria were grown in glycerol medium containing propionate, acetate and stearic 
acid as indicated.(A) Lipids from the Δicl1 mutant (Lane 1) incubated with [1, 2-14C] 
acetate in absence of propionate; (lane 2) incubated with [1,2-
14
C] acetate in presence 
of 0.05 mM unlabeled propionate; or (Lane 3) incubated with [1-
14
C] propionate in 
the presence of 0.05 mM unlabeled propionate; (C) lipids from Erdman. (B), (D): (B) 
The experiment was repeated using the long chain fatty acid, stearic acid (C18) 
instead of acetate (C2).  Lipids from the Δicl1 mutant (Lane 1) incubated with [1-14C] 
stearic acid in absence of propionate; (Lane 2) with [1-
14
C] stearic acid in presence of 
0.05 mM unlabeled propionate; (Lane 3) with [1-
14
C] propionate in the presence of 
0.05 mM unlabeled propionate; (D) lipids from Erdman. (E) Ratio of PDIM to TAG. 
The bands labeled correspond to (1) triacylglycerol, (2) phthiocerol A dimycocerate 
and (3) phthiodiolone dimycocerate. The identity of the PDIM and TAG bands had 
been established previously by mass spectrometry [24]. 
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          To follow the flow of carbon into PDIM, we metabolically labeled the Δicl1 
mutant and a wild-type (wt) Erdman strain, which produces abundant PDIM, with 
14
C-propionate, 
14
C-acetate, and 
14
C-stearic acid.  The peripheral cell wall lipids were 
isolated and analyzed by thin layer chromatography (TLC).  As shown in Figure 2.8, 
14
C label was incorporated into PDIM in both the Δicl1 mutant and the wt strain from 
either 
14
C-acetate or 
14
C-stearic acid. The amount of radiolabel incorporated into 
PDIM from 
14
C-acetate, and 
14
C-stearic acid was enhanced in the Δicl1 mutant in the 
presence of 0.05 mM unlabeled propionate. In the wt strain, which has an intact MCC, 
14
C label from 
14
C-propionate was incorporated into both TAG and PDIM in the 
presence 0.05 mM unlabeled propionate.  Significantly, in the absence of unlabeled 
propionate, the 
14
C-propionate tracer was found only in PDIM.     
          These data indicate that, at least in a high PDIM-producing strain of M. 
tuberculosis, under these in vitro conditions, flux of propionyl-CoA into PDIM is the 
preferred route of detoxification even in the presence of an intact MCC.   These data 
demonstrate that utilization of both long chain fatty acids and the de novo synthesis of 
fatty acids from acetate facilitates formation of the fatty acid-AMP primers to support 
the incorporation of propionyl-CoA into the MB-cell wall lipid PDIM.  
 
2.3.3 Stearic acid is incorporated into M. tuberculosis PDIM without degradation 
through -oxidation.  
          The preceding result does not discriminate between the direct incorporation of 
stearic acid into PDIM as an acyl-primer, from the incorporation of acetyl-CoA 
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released by -oxidation of the stearic acid.  To determine whether intact stearic acid 
is used as a fatty acid primer for PDIM biosynthesis, we metabolically labeled wt 
Erdman and the Δicl1 mutant with double isotope labeled, stearic acid [9,10-3H, 1-14C] 
in the presence of propionate(Figure 2.9). If the stearic acid were catabolized by β-
oxidation the 1-
14
C radiolabel would be released as 
14
C-acetyl-CoA, which can enter 
central metabolism or be used as a substrate by the FAS1 system and incorporated 
into n-fatty acids. Therefore, we predict that if the stearic acid were β-oxidized the 
ratio of 
3
H to 
14
C would change indicating a loss of 
14
C from stearic acid. However, 
we found that the 
3
H: 
14
C ratio within PDIM was virtually identical to the stearic acid 
[9,10-
3
H, 1-
14
C] standard, Table 1. This result demonstrates that long chain fatty acids, 
such as stearic acid, can bypass catabolic -oxidation, and serve as a primer for direct 
incorporation into PDIM.   
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Figure 2.9 Schematic draw for stearic acid incorporation into M. tuberculosis 
PDIM. A specific ratio between isotopes, 
14
C and 
3
H in the double isotope stearic 
acid [9,10-
3
H, 1-
14
C] will be presented in the ratio of labeled PDIM by the isotope, 
when intact stearic acid is incorporated into PDIM. However, if the stearic acid is 
processed by -oxidation and synthesis (M. tuberculosis FAS-I and FAS-II system), 
the ratio in M. tuberculosis PDIM will be shifted from the specific ratio in the double 
isotope stearic acid [9, 10-
3
H, 1-
14
C]. 
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Table 1.1 Stearic acid is incorporated M. tuberculosis PDIM intact, without -
oxidation. 
Stearic acid [9,10-
3
H, 1-
14
C] Dual Isotope Labeling 
 3H:
14
C CPM Ratios of H37Rv icl  
 3
H:
14
C CPM Ratios of Erdman  
 
 Experiment 1 Experiment 2  Experiment 1 Experiment 2 
Total PDIM 0.2962 ± 0.007 0.3087 ± 0.012  0.2784± 0.001 0.2821± 0.004 
Stearic acid 
[9,10-
3
H, 1-
14
C] 
0.2932 ± 0.005 0.3130 ± 0.003  0.2898± 0.002 0.2966± 0.002 
Double-labeled stearic acid [9,10-
3
H, 1-
14
C] was used for metabolic labeling of the 
icl1 strain or Erdman in minimal medium containing glycerol, 0.05mM propionate, 
and 0.05mM stearic acid. After 2 weeks incubation, M. tuberculosis wall surface 
lipids were extracted, and PDIM was purified from the PDIM bands by TLC.  The 
ratio of 
3
H and 
14
C radioactivity (cpm) was determined for both the starting material 
and the extracted PDIM bands. Average and standard deviations were calculated from 
3 technical replicates from each experiment.  
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2.4 Concluding remarks  
          The ability of M. tuberculosis to utilize cholesterol as a carbon source during 
the course of infection has been shown to be critical to its success as a pathogen [19].  
However, the degradation of cholesterol expands the propionyl-CoA pool with 
potentially toxic consequences [5, 6].  In the current study we performed genetic and 
biochemical manipulation of the methylcitrate cycles (MCC) and methylmalonyl 
pathways (MMP) to reveal the metabolic requirements for incorporation of propionyl-
CoA into PDIM and other virulence-associated lipids of the bacterial cell wall.  
          The “choices” open to M. tuberculosis are both catabolic through the 
degradation of propionyl-CoA by the MCC and MMP and the incorporation of its 
products into the TCA cycle, and anabolic through the generation of malonyl-CoA 
primers to act as acceptors of propionyl-CoA in the synthesis of MB lipids.  In the wt 
Erdman strain we observed the incorporation of propionate into PDIM in both the 
presence and absence of exogenous propionate, and the incorporation of propionate 
into TAG only when exogenous propionate was present.  This suggests firstly, that M. 
tuberculosis routes propionate into MB lipids by preference, and secondly, because 
the generation of TAG from propionate requires the MMC, this indicates that the 
MCC is activated in response to additional pressure from propionate.  The “opening” 
of the MCC has the potential to generate more acetyl-CoA, which in turn could 
enhance PDIM production.  This hypothesis is consistent with the observations of 
Jain and colleagues who observed that increased levels of methylmalonyl-CoA led to 
increased synthesis of PDIM and SL-1, and furthermore, impairment in synthesis of 
these lipids lead to reduced virulence in mice [8].  Finally, transcriptional profiling of 
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M. tuberculosis in macrophages over an extended period of infection demonstrated 
that the genes encoding all the steps of the MCC were highly up-regulated throughout 
the duration of the infection [27].  These data argue strongly that the tightly-
coordinated interplay between the MCC, MMP and MB-lipid synthesis is important 
to M. tuberculosis and may represent an “Achilles’ heel” in the metabolic network in 
a bacterium that is highly evolved to survive and persist in its human host. 
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CHAPTER THREE 
Phenotypic profiling for defining genes essential 
 for propionate and fatty acid metabolism 
 
 
 
 
 
 
 
 
 
 
Adapted from 
Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit 
metabolic stress. Lee W, VanderVen BC, Fahey RJ, Russell DG .J Biol Chem. 2013 
Mar 8; 288 (10):6788-800.  
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ABSTRACT 
M. tuberculosis has evolved strategies for reprogramming its carbon metabolism with 
the nutrients in the environment encountered during infection. The intracellular 
survival and replication of the bacterium relies on the ability to coordinate metabolic 
pathways in response to carbon sources available inside its host cell. Cholesterol and 
fatty acids appear key carbon sources, and their 3 carbon product propionyl-CoA can 
lead a metabolic stress. Relieving of the metabolic stress is central to the realignment 
of M. tuberculosis metabolism to these host-derived lipids. In this study, we employed 
TraSH analysis, a global genome profiling method, to define the genes involved in 
propionate and fatty acid metabolism. We identified the pathways and enzymes 
necessary for the detoxification of propionyl-CoA. Our data demonstrate the metabolic 
ability of M. tuberculosis to limit propionyl-CoA stress by incorporation into cell wall 
lipids. These data provide verification that biosynthesis of methyl branched lipids 
serves as a sink for propionyl-CoA, and presents comprehensive genetic 
characterization of the pathways that impact propionate metabolism.  
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3.1 Introduction 
          Nutrient acquisition is crucial for growth and persistence of M. tuberculosis in 
host. Host lipids have long been implicated as primary carbon source during infection 
[1, 2]. Thus, as a new drug target for drug development, lipid metabolism in the 
bacterium is attractive. Conventional drugs target biosynthetic pathways involved in 
cell growth. While these drugs kill efficiently M. tuberculosis grown in vitro, they are 
less active against bacteria in a vegetative, non-replicating state in the host [3, 4]. As 
carbon flow from host nutrients is a significant determinant of the ability of M. 
tuberculosis to replicate and persist in host, these catabolic pathways could also be 
important targets for therapeutic intervention [2, 5-8]. Therefore, information about 
the catabolic metabolism in M. tuberculosis during infection is critical to 
understanding M. tuberculosis pathogenesis and as a novel theme for new 
chemotherapeutic agents that could also be active against drug resistant strains.  
          In order to monitor carbon metabolism, transcriptional profiling has been used. 
Transcriptional expression analysis reveals invaluable information about global 
responses of the bacterium at any given condition and time. In particular, it provides 
critical information for identifying metabolic pathways that M. tuberculosis activates 
and is depend on during infection [9, 10], and for better understanding how drugs and 
drug candidates works in cells and organisms and what gene may be studied further as 
a potential targets [11]. However, this approach generates correlative data and may be 
misleading in situation where message abundance and proteins levels are at variance. 
These limitations can be addressed by using other global genome analysis methods 
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such as transposon insertion-site mapping. For these analyses, mutant pools are 
generated by transposon mutagenesis prior to monitoring survival of each individual 
mutant in a pool following selection [12, 13]. For example, signature tagged 
mutagenesis (STM) which uses a series of sequence tagged transposons, allows 
accurate quantitation of individual mutants in a defined pool[14]. Alternately, 
Transposon Site Hybridization (TraSH), which combines microarray hybridization and 
transposon mutagenesis, provides a genome-wide analysis of all essential genes or 
genomic regions that are required for survival under different conditions [15-18].  This 
latter method is not reliant on a previously characterized signature tag but involves the 
quantitative analysis of input and output pools to identify those mutants enriched or 
depleted by selection through the amplification of the sites of insertion of the 
transposon. 
          As noted in earlier chapter (Chapter 2), the pathways of lipid degradation and 
cell wall synthesis play a critical role in the modulation of the relative levels of 3-
carbon intermediates such as propionyl-CoA, and this regulation is critical to the 
survival of intracellular M. tuberculosis. These data were generated from a very 
targeted approach that artificially controlled carbon flux through the MCC, the MMP 
and into MB cell wall lipids. The simplicity of the resultant phenotypes is, however, 
somewhat misleading because the bacterium undoubtedly possesses complex feedback 
loops and regulatory circuits to control both upstream and downstream pathways of 
central carbon metabolism and biosynthetic pathways.  To expand our study and 
incorporate a more holistic understanding of other bacterial gene products that impact 
propionyl-CoA metabolism we exploited our experimental system to construct a 
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forward genetic screen to identify other genes implicated in this metabolic process.  
For this screen, we used TraSH to identify genes required in detoxification of 
propionate. In this chapter, by using TraSH, we generate a comprehensive set of genes 
that impact propionate metabolism. In conditions of propionate stress, the important 
roles of biosynthesis of methyl-branched polyketides revealed by TraSH demonstrate 
that metabolic adaptation of M, tuberculosis through carbon re-routing is critical in 
utilization of host derived lipids.  
 
3.2 MATERIAL and METHODS 
Bacterial strains and culture conditions 
Mycobacterial strains were maintained in Middlebrook 7H9 medium (Difco) 
supplemented with 0.2% glycerol, OADC (oleate 0.5% BSA, 0.2% dextrose, 0.085% 
NaCl) and 0.05% tyloxapol. Kanamycin (20 g/ml) or hygromycin (50 g/ml) were 
used where necessary. Mycobacterium smegmatis mc2–155 was cultured on LB agar. 
M. tuberculosis H37Rv were cultured on Middlebrook 7H10 agar supplemented with 
OADC.  
          For growth on defined carbon sources, strains were grown without shaking in 
minimal medium (0.5 g/L asparagine, 1.0 g/L KH2PO4, 2.5 g/L Na2HPO4, 50 mg/L 
ferric ammonium citrate, 0.5 g/L MgSO4,7H2O, 0.5 mg/L CaCl2 and 0.1 mg/L ZnSO4, 
10 mM glycerol, and  0.05% tyloxapol) containing propionate or fatty acids (Sigma). 
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Long chain fatty acids were prepared as described in Chapter 2. Bacterial growth was 
monitored by measuring optical density at 600 nm. 
  
Mutant Strains 
The acs:Tn mutant
 
(Transposon insertion at 866 bp), the prpD:Tn mutant (Transposon 
insertion at 643 bp), and prpC:Tn mutant (Transposon insertion at 1019 bp) were 
constructed using MycomarT7 in H37Rv in a Δicl1 background. To construct a PDIM- 
(or SL-1) deficient mutant in the Δicl1 background, an internal 1066-bp fragment of 
ppsD  (Rv2934) and an internal 1044-bp fragment of pks2 (Rv3825) was PCR 
amplified and cloned into the plasmid pMV307 (Km
R
), a derivative of pMV306 
without the int gene, which was used to construct the ppsD knockout mutant by single 
crossover. Then plasmid DNA was UV irradiated and electroporated into the icl1 
strain. Transformants were selected on Kanamycin and confirmed by PCR. To 
quantify survival of M. tuberculosis in macrophage infection experiments we 
transformed the relevant H37Rv strains with pVV16-smyc’::mCherry expressing the 
fluorescent protein mCherry driven by the smyc promoter.  
 
Construction of Transposon Mutant Libraries  
Transposon libraries were made by using the Transposon donor phagemid 
MycoMarT7 (GenBank accession no. AF411123) in the Δicl1 H37Rv background as 
described. For preparation of high concentration stock of phagemid (1x10
11
/PFU), the 
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phagemid was transduced into M. smegmatis MC2, and incubated to allow form 
plaque at 30°C, 20 of plaques of which were tested for temperature sensitivity at 37°C. 
The isolated plaque which was temperature sensitive was amplified and concentrated 
by re-tranduction into M. smegmatis. For M. tuberculosis transduction, the bacterial 
cultures grown to OD600 of 0.8-1.0 in liquid culture were washed twice with MP buffer 
(50 mM Tris, pH7.5/ 150 mM NaCl/ 10 mM MgSO4 / 2 mM CaCl2) and concentrated 
in 1/10 of the original culture volume in MP buffer. Then cells were infected with 
1x10
10
 phage per ml of bacterial culture for 4 hours at 37°C. The mixture was plated 
on 7H10 OADC 20 g/ml kanamycin, and libraries were collected by scraping 
colonies from plates. Each library consisted of at least 1x10
5
 independent mutants.  
 
Transposon site hybridization (TraSH)  
Approximately 2x10
6
 CFUs from an aliquot of the library were inoculated into 
minimal media either containing 10 mM glycerol, or 10 mM glycerol with 0.05 mM 
propionate and 0.05 mM stearic acid, 2mM acetate, or palmitic acid. To limit the over-
selection of fast growers, the cultures were only allowed to grow up to an OD600 0.3. 
Then, the control pool and the propionate/fatty acid rescue pool were compared, two 
biological replicates and two technical replicates, using TraSH.   
Construction of high density microarray A custom-designed, high-density microarray 
was used to identify the insertion sites.  This array, synthesized by Agilent 
Technologies, consisted of 60 mer oligos every 350 bp of the M. tuberculosis H37Rv 
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chromosome.  We calculated that this oligo density would allow size-selected (200-
500 bp) labeled probes to hybridize to at least one oligo and therefore provide 
sufficient coverage to identify the majority of insertion sites.   
 Generation of labeled RNA for TraSH analysis Genomic DNA was isolated from 
mutant pools as described. Fragment from 500 bp to 2000 bp by digested partially by 
HinPI and MspI (New England Biolabs) was ligated to the adapter. To amplify the 
transposon junctions, PCR reaction was followed with the ligated DNA.  
 
 
 
 
Then, PCR products from 250bp to 500bp was used as for in vitro transcription with 
T7 polymerase to make template RNA (Ambion, Austin, TX). After transcription, 
RNA was labeled with fluorescein (Alexa-555 and 647). The generated probe was 
hybridized as described. Images from the signal from hybridized RNA was detected 
with a Scanarray microarray scanner and analyzed with GeneSpring GX software  
Table 3.1 PCR condition for probe amplification 
Primer 1 and adapter primer Primer 2 and adapter primer 
temp (°C) min cycle temp (°C) min cycle 
95 10 1 95 10 1 
94 0.5 5 94 0.5 5 
69 0.5 72 2 
72 1.5 
94 0.5 5 94 0.5 5 
67 0.5 70 2 
70 1.5 
94 0.5 15-25 94 0.5 15-25 
65 0.5 68 2+ 
5s /cycle 68 1.5 + 
5s /cycle 
72 5 1 72 5 1 
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 (Agilent). Mutants that were significantly over- (or under-) represented after screen 
were defined using the following criteria: arbitrary fluorescence intensity >300 in one 
of the channels, fluorescence ratio >3 and t test p value <0.05.  
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Table 3.2 Bacterial strains and plasmids 
Strains Relevant characteristics reference 
Icl1  H37Rv icl1(Rv0467)  
ppsD H37Rvicl1 , ppsD(Rv2934):: KO:: KmR This study 
Pks2 H37Rvicl1 , pks2(Rv3825):: KO:: KmR This study 
Acs Tn H37Rvicl1 , acs(Rv3667)::Tn KmR This study 
prpD Tn H37Rvicl1 , prpD(Rv1130)::Tn KmR This study 
prpC Tn H37Rvicl1 , prpC(Rv1131)::Tn KmR This study 
Plasmids 
Name Relevant characteristics reference 
pMV307 Km
R
 This study 
MycoMarT7 Km
R
 [16] 
Primers 
Name Oligo nucleotide sequence, 5` 3` use 
ppsD –F GACGATGAACCGCGAACTGGACC Knock out ppsD 
ppsD- R GCTTTCGGTCCATTCGGCATCG Knock out ppsD 
ppsD-CF GCTTATCGACGGCGACGAGGTGGT Confirm ppsD KO 
ppsD-CR AGCACCCGCACCAGCCCTTTCAA Confirm ppsD KO 
Pks2-F GCTGACGGATCTGCACAACGCTG Knock out pks2 
Pks2-R TACAGGCCCTGCTGCGAACGA Knock out pks2 
Pks2-CF AGGAGTGCTGTCAGCCGAAGATGGGG Confirm pks2 KO 
Pks2-CR GGTAGCGGTCACATCAGAGGCAGCG Confirm pks2 KO 
Adaptor prim GTCCAGTCTCGCAGATGATAAGG  TraSH 
TN 1 CCCGAAAAGTGCCACCTAAATTGTAAGCG TraSH 
TN 2 CGCTTCCTCGTGCTTTACGGTATCG TraSH 
Adapter 1 CGACCACGACCA 3′ C6-TFA TraSH 
Adapter 2 AGTCTCGCAGATGATAAGGTGGTCGTGGT TraSH 
83 
 
3.3 RESULTS and DISCUSSION 
3.3.1 Genetic profiling of propionate, stearic acid (C18:0) and palmitic acid 
(C16:0) metabolism  
        To identify loci of interest we designed a TraSH screen to reveal mutants that 
were incapable of detoxifying propionyl-CoA, and that were unable to grow in the 
presence of propionate when provided long chain fatty acids as a means of rescue 
(Figure 3.1). We focused on saturated C18 and C16 fatty acid to provide metabolic 
rescue because we have shown previously that these chain length fatty acids are an 
effective primer for synthesis of PDIM, and are known to be one of the more abundant 
fatty acid species in the granulomatous lesion of TB as well as in the mammalian host 
[19].  We constructed a 10
5 
CFU library in H37Rv Δicl1 using the mariner transposon 
(MycomarT7). This library was grown in minimal medium containing 10 mM glycerol 
(input pool) versus minimal medium containing 10 mM glycerol, 0.05 mM propionate, 
and 0.05 mM stearic acid (output pool).  
          To identify genes that impact the metabolism of fatty acid (stearic acid, palmitic 
acid, or acetate) or propionate, we compared the input and output pools of mutants to 
quantify those mutations that were under-, or over-represented following selection.  As 
shown in Figure 3.2, the acetate, stearic acid and palmitic acid TraSH analysis 
revealed core over-represented mutations and under-represented mutations that 
satisfied our statistical cut-off (3-fold change, P<0.05, intensity 300<) (Table 1-4). 
These genes are arranged diagrammatically in context of their annotation and 
assignment to known metabolic pathways (Figure 3.3).  We hypothesized that those 
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mutants lost during selection will include genes that are required for the fatty acid 
uptake and rescue from propionyl-CoA-mediated toxicity, whilst those mutants 
enriched in the screen would include genes that mitigate propionyl-CoA-mediated 
toxicity and facilitate growth.   Not surprisingly, the most dominant themes to emerge 
from the screen are loci involved in methyl-branched lipid biosynthesis, the MCC, and 
-oxidation (Figure 3.3).  
          To validate the TraSH data, we generated and determined the phenotype of 2 
double mutants; Δicl1:KO-ppsD (PDIM synthesis) and Δicl1: KO-pks2 (SL-1 
synthesis).  While both mutants grew normally on control medium, neither the PDIM- 
nor SL-1-deficient double mutants could grow in propionate-containing medium 
supplemented by either acetate or stearic acid (Figure 3.4A-C), whereas the parent 
Δicl1 mutant grew in propionate supplemented with either acetate or stearic acid.   
These results both validate the genetic screen and provide biochemical verification of 
the phenotypes of the double mutants. 
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Figure 3.1 Schematic draw for TraSH screen. Mutants that are incapable of 
detoxifying propionyl-CoA in presence of fatty acids, or unable to grow in the 
presence of propionate will be less represented in Pool 2 than Pool 1, and these 
mutations can be identified by TraSH analysis.  
 
 
 
 
 
86 
 
3.3.2 Under represented mutants 
          Prominent among under-represented mutations were those genes involved in the 
biosynthesis of MB-lipids; locus Rv2930-Rv2950 for PDIM synthesis, Rv3820-
Rv3825c for SL-1 synthesis, Rv1180-Rv1185 for PAT and DAT synthesis, and 
Rv1527c/Pks5-Rv1528c/PapA4, which are related to mycobacterial 
lipooligosaccharide (LOS) biosynthetic genes in M. marinum and M. canetti.  While M. 
tuberculosis  is not reported to make LOS, pks5 has been implicated in mycocerosoic 
acid synthesis, and mutants defective in expression of pks5 have a marked growth 
defect in mice [20]. These data provide independent verification that the biosynthesis 
of MB lipids provides a sink for excess propionyl-CoA and is consistent with the 
observation that increases in propionate pools enhances the biosynthesis of PDIM and 
SL-1 or longer MB-lipids.  In addition, mutants of a transcriptional regulator, phoP 
(phoP 10.1X P=0.00007, phoR 2.2X P=0.003), were also enriched following selection.  
We found previously that phoP mutants exhibit a marked enhancement in the 
production of PDIM and other mycocerosates [21], which is consistent with a previous 
report that documented that PhoP mutants exhibited enhanced resistance to both 
propionate toxicity and to 3-nitropropionate, a known inhibitor of ICL activity [22].   
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Figure 3.2 TraSH analysis. (A) Fold change cross the M. tuberculosis genome. In all 
three screens, the locus for biosynthesis of PAT, PDIM, and SL-1 were commonly 
underrepresented (highlighted by blue) while mutations in genes of MCC were over-
represented (highlighted by red). Comparison of under-representors (B) or over-
representors (C) from acetate (C2) & propionate, palmitic acid (C16) & propionate, 
and stearic acid (C18) & propionate TraSH.  
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Figure 3.3 Phenotypic TraSH screen identifies genes involved in propionate 
utilization and toxicification.  Graphical illustration of the differentially-represented 
genes in context of the metabolic pathways most relevant to propionate utilization and 
detoxification. Genes required for Δicl1 M. tuberculosis growth in the presence 
propionate and long chain fatty acids as a means of propionate toxicity rescue are 
indicated in blue text. Genes that when mutated, enhance Δicl1 M. tuberculosis growth 
in the presence propionate and long chain fatty acids indicated in red text. The 
differentially represented genes are shown in relation to the relevant carbon metabolic 
pathways; synthesis of non-essential MB-lipids, synthesis of non-MB-lipids, the 
MMC, and genes involved in the -oxidation breakdown of long chain fatty acids. All 
genes selected were >3x-fold over-represented or >3x-fold under-represented with P-
values < 0.05. The full list of over-represented and under-represented genes is 
provided in supplemental material, Table 3.1-4. 
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3.3.3 Over represented mutants 
          Amongst those mutations that were over-represented, or positively-selected in 
the screen, the most striking were those genes implicated in the metabolism of 
propionate through MCC (Figure 3.3). The screen was conducted in a Δicl1 mutant 
background, thus the MCC was inactivated at the 2-methylisocitrate to succinate and 
pyruvate step.  This suggests strongly that the accumulation of all three upstream 
intermediates, propionyl-CoA, 2-methylcitrate and 2-methylisocitrate are, individually 
or collectively, toxic to M.tuberculosis.  The inactivation of Rv1129c, Rv1130/prpD, 
or Rv1131/prpC resulted in marked enhancement of growth, which implies that 2-
methycitrate and/or 2-methylisocitrate are more toxic than propionyl-CoA; Rv1129c 
(103.7X, P=0.003), Rv1130 (136.8X, P=0.0002), Rv1131 (15.6X, P=0.01), and 
Rv3667 (17.7X, P=0.04).  This is consistent with the putative mechanism of 
propionate toxicity in Salmonella where 2-methlycitrate is believed toxic [23].   
          Finally, we also found that a mutation in Rv2497c (pdhA) encoding a subunit of 
the branched-chain keto acid dehydrogenase [24] was advantageous to growth. It is 
therefore possible that a significant fraction of propionyl-CoA in M. tuberculosis  may 
be produced via catabolism of MB-amino acids such as valine and isoleucine, in 
addition to the breakdown of cholesterol. To validate those loci identified as over-
represented in the TraSH screen, we examined the phenotypes of the double knockout 
mutants, Δicl1: Tn::Rv3667 (an acetyl-CoA synthase), Δicl1: Tn::prpC (citrate 
synthase, GLTA1), and Δicl1: Tn::prpD (methylcitrate synthase).   
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Figure 3.4 Validation of the genes implicated in propionate utilization and 
detoxification in Δicl M. tuberculosis.  Genes identified by TraSH screen were 
validated through the generation of double mutants and characterized by growth 
phenotype (A-C) Genes negatively-selected for involved in MB-containing lipid 
biosynthesis.  Growth of the Δicl1 parental strain and Δicl1:KO-ppsD (PDIM 
biosynthesis), and Δicl1:KO-pks2 (SL-1 biosynthesis) double mutant strains were 
assessed in minimal media containing glycerol, propionate and (A) 1 mM acetate, or 
(B) 0.05mM stearic acid, or (C) absent any fatty acid supplement.  In each instance the 
mutants exhibited defective growth in fatty acid with propionate (A and B) yet grew 
normally in minimal medium with glycerol (C). (D-F) Genes positively-selected as 
being involved in propionate utilization and the generation of toxic intermediates. 
Growth of the Δicl1 parental strain (D) Δicl1:Tn acs (Rv3667) (E) Δicl1:Tn prpD 
(Rv1130), (F) Δicl1:Tn prpC (Rv1131) in minimal media containing glycerol and 0.05 
mM propionate (D-E) or 0.1 mM propionate (F). These mutants all grew normally in 
minimal medium and each of the second mutations conferred partial resistance to 
propionate toxicity, consistent with their enrichment under propionate selection.  
Results are representative of three experiments.    
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We included Rv3667 in this analysis because, although it is annotated as an acetyl-
CoA synthase, it was strongly selected for in the TraSH screen (enriched almost 18 
fold) and may function as a propionyl-CoA  synthetase, required for the conversion of 
propionate to propionyl-CoA.  All 3 double mutant strains exhibited resistance to 
propionate toxicity (0.05 mM and 0.01 mM) and were able to grow to varying degrees 
in propionate-containing medium, while the growth of the parent, Δicl1 parent strain 
was strongly inhibited (Figure 3.4D-F). The prolonged lag period observed in the 
growth of these mutants is not due to suppressor mutations because similar lag periods 
are observed on the passing of the mutants into fresh culture medium.  Again, these 
data provide biochemical verification of the phenotypes of the double mutants.  
 
3.3.4 Fatty acid metabolism  
          The above themes have been selected because they validate the TraSH screen 
and the selection pressure applied to the mutant pools, however, there are other, less 
obvious sets of genetic loci that have been enriched or depleted from the mutant pool.  
Notably, several fadD and fadE genes appeared as under-represented, suggesting these 
may be involved in stearic acid catabolism and expansion of the acetyl-CoA pool, in 
addition to stearic acids role as an acyl primer. This finding is particularly interesting 
given the high redundancy of genes thought to be involved in -oxidation of fatty 
acids [25] because it implies that there may be at least a measure of substrate 
specificity within this pathway.   
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          For further identification of a set of genes for a fatty acid catabolism, we 
constructed a 10
5 
CFU library in CDC1551 using the mariner transposon 
(MycomarT7). This library was grown in minimal medium containing 10 mM glycerol 
(input pool) versus minimal medium containing 0.05 mM stearic acid (output pool-1). 
To exclude genes that are related to stearic acid toxicity, we included a culture 
containing 10 mM glycerol and 0.05 mM stearic acid (output pool-2). To identify 
genes that impact the utilization of stearic acid, we compared the input and output 
pools of mutants as described in the propionate TraSH data. The TraSH analysis 
revealed most of genes that were significant in stearic acid utilization were also 
presented under the condition of stearic acid toxicity. However, we found a subset of 
genes that are under-represented in stearic acid utilization, but are over-represented (or 
not represented), which were likely involved in stearic acid utilization such as its 
import (3-fold change, P<0.05, intensity 300<) (Table 3, 4). 
 
3.3.5 Competition for fatty acid primer 
          Finally we found that mutations in genes involved in the synthesis of certain 
non-MB-lipids such as mycobactin (mbtB, mbtK) [26], and phospholipid (lysX, plsC) 
[27], conferred a growth advantage, which was unexpected. However M. tuberculosis 
requires C16-C20 fatty acids (or C12 in mycobactin) to synthesize phospholipids and 
mycobactin [28], as well as MB-lipids such as PDIM [29].   Therefore, because 
biosynthesis pathways of non-MB-lipids and MB-lipids likely compete for these fatty 
acid primers, the reduced carbon flow into biosynthesis of non-MB lipids may lead to 
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the increased availability of fatty acid primers that can be redirected into MB-lipids, 
thus enhancing detoxification. 
 
3.4 Concluding remarks 
          The TraSH data provide insights into the re-routing of carbon flow to limit 
propionate toxicity, which is consistent with the observations shown in Chapter 2. The 
data suggest that the biosynthesis of methyl branched polyketides such as PDIM, SL-1, 
and PAT, plays important roles in reducing propionyl-CoA level by incorporating 
propionyl-CoA into their phthioceranic acids in form of methyl groups. We also found 
that transposon mutants with insertions in any gene in the methyl citrate cycle were 
over-represented, suggesting that the toxic intermediates in the methyl citrate cycles 
likely include 2 methyl (iso)citrate or propionyl-CoA rather than propionate. 
Furthermore, TraSH data revealed a subset of genes, which may be involved in filling 
missing pathways in methyl-branched lipid synthesis, propionate detoxification or 
fatty acid processing.  
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Table 3.3 Under represented mutants in stearic acid TraSH 
Gene Name probe-ID Ratio Function  
Rv0147 Rv0147-1/5 -4.49 aldehyde dehydrogenase  
Rv0180c Rv0180c-1/4 -9.21 conserved transmembrane protein 
Rv0244(fadE5) Rv0244c-1/5 -5.50 acyl-coa dehydrogenase fade5 
Rv0244c-2/5 -5.92 
Rv0244c-3/5 -4.34 
Rv0295c Rv0295c-2/2 -3.35 conserved hypothetical protein 
Rv0315 Rv0315-1/2 -3.19 possible beta-1,3-glucanase  
Rv0544c Rv0544c-1/1 -5.59 conserved transmembrane protein 
Rv0545c(pitA) Rv0545c-2/4 -4.64 low affinity inorganic phosphate transporter  
Rv0554(bpoC) Rv0554-1/2 -3.08 possible peroxidase bpoc  
Rv0686 Rv0686-2/2 -3.24 probable membrane protein 
Rv0691c Rv0691c-1/1 -4.97 probable transcriptional regulator 
BT-v0804&Rv0805  -6.65 tn>rv0805 : bt-rv0804&rv0805 
Rv0820(phoT) Rv0820-2/3 -3.02 probable phosphate-transport abc transporter  
Rv0996 Rv0996-2/3 -3.03 conserved transmembrane protein 
Rv1161(narG) Rv1161-9/10 -3.11 probable respiratory nitrate reductase 
Rv1180(pks3) Rv1180-4/4 -3.27 polyketide synthase 3 
Rv1181(pks4) Rv1181-10/14 -5.22 polyketide synthase 4 
Rv1182(papA3) Rv1182-1/4 -3.99 probable polyketide synthase associated protein  
Rv1185c(fadD21) Rv1185c-2/5 -3.12 probable fatty-acid--coa ligase  
Rv1185c-3/5 -3.47 
Rv1185c-5/5 -5.29 
Rv1253(deaD) Rv1253-4/5 -3.27 cold-shock dead-box protein a homolog  
Rv1256c(cyp130) Rv1256c-3/4 -3.14 proba ble cytochrome p450 130  
Rv1457c Rv1457c-2/3 -3.66 probable integral membrane abc transporter 
Rv1528c(papA4) Rv1528c-2/2 -3.31 polyketide synthase associated protein  
Rv1566c Rv1566c-1/2 -3.93 possible inv protein 
Rv1626 Rv1626-1/2 -5.82 probable tcs transcriptional regulator 
Rv1709 Rv1709-1/2 -3.28 conserved hypothetical protein 
Rv1761c Rv1761c-1/1 -3.19 hypothetical exported protein 
BT-PPE27&PE19  -3.42 tn>rv1791 : bt-ppe27&pe19 
Rv1946c(lppG) Rv1946c-1/1 -3.43 possible lipoprotein 
Rv2027c(dosT) Rv2027c-5/5 -3.60 tcs sensor histidine kinase 
Rv2135c Rv2135c-1/2 -4.50 conserved hypothetical protein 
Rv2418c Rv2418c-1/2 -3.19 hypothetical protein 
BT-fas&Rv2525c  -3.37 tn>rv2524c : bt-fas&rv2525c 
Rv2535c(pepQ) Rv2535c-1/3 -4.10 probable cytoplasmic peptidase  
Rv2535c-3/3 -4.95 probable cytoplasmic peptidase  
Rv2625c Rv2625c-1/3 -3.02 probable transmembrane protein 
Rv2710(sigB) Rv2710-1/3 -7.54 rna polymerase sigma factor  
Rv2723 Rv2723-1/3 -3.25 conserved transmembrane protein 
Rv2752c Rv2752c-5/5 -3.86 conserved hypothetical protein 
Rv2781c Rv2781c-3/3 -3.38 possible ala rich oxidoreductase 
Rv2867c Rv2867c-1/2 -3.66 gcn5-related n-cetyltransferase  
Rv2929 Rv2929-1/1 -5.03 hypothetical protein 
Rv2930(fadD26) Rv2930-2/5 -8.71 fatty-acid-coa ligase  
Rv2930-3/5 -5.04 
Rv2930-5/5 -3.77 
Rv2931(ppsA) Rv2931-11/16 -6.67 phenolpthiocerol synthesis type-i  
polyketide synthase ppsa Rv2931-12/16 -7.28 
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Rv2931-7/16 -4.82 
Rv2932(ppsB) Rv2932-11/13 -3.17 phenolpthiocerol synthesis type-i  
polyketide synthase ppsb Rv2932-2/13 -6.38 
Rv2932-8/13 -4.88 
Rv2933(ppsC) Rv2933-10/19 -5.84 phenolpthiocerol synthesis type-i  
polyketide synthase ppsc Rv2933-13/19 -4.45 
Rv2933-2/19 -7.13 
Rv2933-7/19 -7.28 
Rv2933-8/19 -4.34 
Rv2934(ppsD) Rv2934-10/16 -5.63 phenolpthiocerol synthesis type-i  
polyketide synthase ppsd Rv2934-16/16 -10.2 
Rv2934-8/16 -4.25 phenolpthiocerol synthesis type-i  
polyketide synthase ppsd Rv2935(ppsE) Rv2935-11/13 -5.94 
Rv2935-12/13 -5.43 
Rv2935-2/13 -3.46 
Rv2935-3/13 -3.39 
Rv2935-4/13 -3.49 
Rv2935-5/13 -3.24 
Rv2935-6/13 -5.63 
Rv2936(drrA) Rv2936-2/3 -4.61 probable daunorubicin-dim-transport atp-binding 
protein  
Rv2939(papA5) Rv2939-1/4 -9.39 polyketide synthase associated protein  
Rv2940(mas) Rv2940c-10/18 -7.08 probable multifunctional  
mycocerosic acid synthase   Rv2940c-14/18 -3.37 
Rv2940c-17/18 -3.17 
Rv2940c-18/18 -4.31 
Rv2940c-3/18 -3.26 
Rv2940c-7/18 -4.32 
Rv2941(fadD28) Rv2941-1/5 -4.80 fatty-acid-coa ligase fadd28  
Rv2941-4/5 -9.08 
Rv2950(fadD29) Rv2950c-4/5 -3.98 probable fatty-acid-coa ligase fadd29  
Rv2950c-5/5 -4.08 
Rv3028c(fixB) Rv3028c-3/3 -4.91 probable electron transfer flavoprotein 
Rv3110(moaB1) Rv3110-1/1 -3.29 probable pterin-4-alpha-carbinolamine 
 dehydratase  
Rv3126c Rv3126c-1/1 -4.07 hypothetical protein 
BT-PPE50&PPE51  -3.88 tn>rv3136 :  
Rv3193c Rv3193c-3/9 -3.43 probable conserved transmembrane protein 
Rv3193c-6/9 -3.50 
Rv3193c-9/9 -4.25 
Rv3220c Rv3220c-2/4 -5.96 probable tcs sensor kinase 
Rv3255c(manA) Rv3255c-4/4 -4.05 probable mannose-6-p isomerase  
Rv3274c(fadE25) Rv3274c-1/3 -3.28 acyl-coa dehydrogenase  
Rv3403c Rv3403c-1/5 -3.96 hypothetical protein 
BT-v3415c&whiB3  -4.60 rv3415c<tn>rv3416  
Rv3506(fadD17) Rv3506-5/5 -3.05 fatty-acid-coa synthetase  
Rv3530c Rv3530c-1/2 -3.03 possible oxidoreductase 
Rv3649 Rv3649-1/6 -3.49 probable helicase 
Rv3682(ponA2) Rv3682-4/7 -5.89 probable penicillin binding protein  
Rv3698 Rv3698-1/5 -4.11 conserved hypothetical protein 
Rv3732 Rv3732-1/3 -3.69 conserved hypothetical protein 
Rv3755c Rv3755c-2/2 -4.29 conserved hypothetical protein 
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Rv3820c(papA2) Rv3820c-1/4 -4.32 possible polyketide synthase  
associated protein papA2 Rv3820c-3/4 -3.13 
Rv3824c(papA1) Rv3824c-4/5 -5.16 probable polyketide synthase  
associated protein papA1 Rv3824c-5/5 -4.31 
Rv3825c(pks2) Rv3825c-1/18 -4.01 probable polyketide synthase pks2 
Rv3825c-12/18 -4.07 
Rv3825c-13/18 -3.67 
Rv3825c-16/18 -3.40 
Rv3825c-17/18 -3.44 
Rv3825c-4/18 -4.65 
Rv3825c-8/18 -5.12 
Rv3825c-9/18 -6.42 
List of genes that are under-represented by TraSH analysis in the stearic acid rescue screen. 
All genes have >3 fold under representation in the pool of stearic acid and propionate screen 
condition with a P-value <0.05. Genes listed in red are related to PDIM or SL-1. Probes in 
intergenic regions are shown as BT Rvxxxx& Rvxxxx. The numbers beside the genes indicate 
the position of probe within the gene; for example, Rv3825c-1/18 means that this probe is the 
first probe out of 18 internal probes within Rv3825c. 
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Table 3.4 Over represented mutants in stearic acid TraSH 
Gene name probe-ID Ratio Function  
Rv0041(leuS) Rv0041-7/8 12.79 leucyl-tRNA synthetase  
Rv0042c Rv0042c-1/1 12.65 possible transcriptional regulatory protein  
Rv0174(mce1F) Rv0174-1/4 3.60 mce-family protein mce1f 
Rv0199 Rv0199-1/2 4.33 conserved membrane protein 
Rv0236c Rv0236c-12/12 4.18 conserved membrane protein 
Rv0238 Rv0238-1/1 3.28 possible transcriptional regulator  
Rv0247c Rv0247c-1/2 5.31 probable succinate dehydrogenase 
Rv0247c-2/2 3.08 
Rv0248c Rv0248c-1/6 3.53 probable succinate dehydrogenase 
Rv0248c-3/6 3.48 
Rv0249c Rv0249c-1/2 6.35 probable succinate dehydrogenase 
Rv0346c(ansP2) Rv0346c-4/4 4.53 possible l-asparagine permease  
BT-purA&Rv0358  5.75 rv0357c<tn>rv0358  
Rv0384c(clpB) Rv0384c-1/8 5.98 probable endopeptidase  
BT-mmpS1&fadD30  3.51 rv0403c<tn>rv0404  
BT-lpqL&lpqM  4.46 tn>rv0419  
Rv0426c Rv0426c-1/1 7.24 possible transmembrane protein 
Rv0455c Rv0455c-1/1 7.22 conserved hypothetical protein 
Rv0485 Rv0485-1/4 7.21 possible transcriptional regulatory protein 
Rv0485-2/4 5.51 
Rv0654 Rv0654-3/5 16.73 probable dioxygenase 
Rv0655(mkl) Rv0655-1/3 10.93 possible ribonucleotide-transport  
abc transporter  Rv0655-2/3 9.87 
Rv0731c Rv0731c-3/3 6.12 possible s-adenosylmethionine-dependent 
 methyltransferase. 
BT-Rv0756c&phoP  10.13 rv0756c<tn>rv0757  
Rv0785 Rv0785-2/5 5.29 conserved hypothetical protein 
Rv0877 Rv0877-1/3 4.68 conserved hypothetical protein 
Rv0908(ctpE) Rv0908-3/7 4.69 probable metal cation transporter  
atpase p-type ctpe 
Rv0986 Rv0986-1/2 3.06 probable adhesion component transport  
abc transporter 
Rv0987 Rv0987-5/7 6.61 probable adhesion component transport  
abc transporter 
Rv0993(galU) Rv0993-1/2 7.55 probable utp--glucose-1-puridylyltransferase  
Rv1002c Rv1002c-2/4 14.40 conserved membrane protein 
Rv1013 Rv1013-1/4 3.01 putative polyketide synthase pks16 
Rv1058(fadD14) Rv1058-3/5 10.19 probable fatty-acid-coa ligase  
Rv1072 Rv1072-1/3 3.25 conserved transmembrane protein 
Rv1072-2/3 6.40 
Rv1094(desA2) Rv1094-1/2 7.48 possible acyl desaturase  
Rv1099c Rv1100-1/3 4.76 conserved hypothetical protein 
Rv1108c(xseA) Rv1108c-1/3 4.45 probable exodeoxyribonuclease vii  
BT-Rv1128c&Rv1129c  35.60 tn>rv1128c : bt-rv1128c&rv1129c 
Rv1129c Rv1129c-1/4 9.16 probable transcriptional regulator protein 
Rv1129c-2/4 17.28 
Rv1129c-3/4 103.73 
Rv1129c-4/4 8.43 
Rv1130(prpD) Rv1130-1/4 8.44 conserved hypothetical protein 
Rv1130-2/4 136.86 
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Rv1130-3/4 98.29 
Rv1130-4/4 17.72 
Rv1131(prpC) Rv1131-2/4 15.67 probable citrate synthase  
Rv1131-3/4 11.72 
Rv1131-4/4 5.38 
Rv1166(lpqW) Rv1166-3/5 6.56 probable conserved lipoprotein  
BT-Rv1194c&PE13  9.89 rv1194c<tn>rv1195  
Rv1194c Rv1194c-3/4 17.44 conserved hypothetical protein 
 Rv1194c-4/4 4.86  
Rv1202(dapE) Rv1202-1/3 3.40 probable succinyl-diaminopimelate 
 desuccinylase  
Rv1231c Rv1231c-1/2 3.04 probable membrane protein 
Rv1250 Rv1250-4/5 7.16 probable integral membrane protein 
Rv1315(murA) Rv1315-4/4 8.38 probable udp-n-acetylglucosamine  
1-carboxyvinyltransferase  
Rv1339 Rv1339-2/2 16.86 conserved hypothetical protein 
Rv1344 Rv1344-1/1 3.13 probable acyl carrier protein  
Rv1348 Rv1348-7/8 6.96 probable abc transporter 
Rv1349 Rv1349-1/5 3.42 probable abc transporter 
Rv1415(ribA2) Rv1415-3/4 5.40 riboflavin biosynthesis protein  
Rv1430(PE16) Rv1430-4/5 5.21 pe family protein 
Rv1432 Rv1432-1/4 3.83 probable dehydrogenase 
Rv1469(ctpD) Rv1469-3/5 3.21 probable cation transporter  
Rv1530(adh) Rv1530-2/3 3.40 probable alcohol dehydrogenase adh 
Rv1562c(treZ) Rv1562c-1/5 7.03 maltooligosyltrehalose trehalohydrolase  
Rv1609(trpE) Rv1609-1/4 7.34 probable anthranilate synthase component  
Rv1640(lysX) Rv1640c-4/10 4.31 possible lysyl-trna synthetase 2  
Rv1640c-5/10 3.92 
Rv1640c-7/10 3.27 
Rv1647 Rv1647-2/2 5.94 conserved hypothetical protein 
Rv1699(pyrG) Rv1699-5/5 3.07 probable ctp synthase 
Rv1890c Rv1890c-1/2 3.03 hypothetical protein 
Rv1896c Rv1896c-1/2 3.17 conserved hypothetical protein 
Rv1941 Rv1941-2/2 5.01 probable short-chain type 
 dehydrogenase/reductase 
Rv1992c(ctpG) Rv1992c-5/7 3.62 probable metal cation transporter  
Rv2071c(cobM) Rv2071c-1/2 7.01 probable precorrin-4 c11-methyltransferase  
BT-0000&prcA  7.44 rv2108>tn<rv2109c  
Rv2156c(murX) Rv2156c-1/4 10.53 probable phospho-n-acetylmuramoyl 
-pentappeptidetransferase murx 
Rv2173(idsA2) Rv2173-3/3 3.16 probable  geranylgeranyl pyrophosphate 
 synthetase  
Rv2191 Rv2191-4/6 9.73 conserved hypothetical protein 
Rv2225(panB) Rv2225-1/2 3.34 probable 3-methyl-2-oxobutanoate 
 hydroxymethyltransferase  
Rv2238c(ahpE) Rv2238c-1/1 14.57 probable peroxiredoxin  
Rv2351c(plcA) Rv2351c-2/5 3.34 probable phospholipase c 1  
Rv2383c(mbtB) Rv2383c-9/12 16.34 phenyloxazoline synthase  
Rv2482c(plsB2) Rv2482c-7/7 3.28 probable glycerol-3-phosphate 
 acyltransferase  
Rv2483c(plsC) Rv2483c-1/5 4.00 possible transmembrane phospholipid 
 biosynthesis enzyme Rv2483c-3/5 3.51 
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Rv2483c-5/5 4.25 
BT-Rv2506&Rv2507  30.90 tn>rv2507  
Rv2507 Rv2507-2/2 5.24 conserved pro rich membrane protein 
Rv2559c Rv2559c-3/4 6.06 conserved hypothetical protein 
Rv2586c(secF) Rv2586c-4/4 3.16 protein-export membrane protein  
BT-Rv2596&Rv2597  6.95 tn>rv2597 : bt-rv2596&rv2597 
Rv2634c(PE_PGRS46) Rv2634c-2/7 4.15 pe-pgrs family protein 
Rv2677c(hemY) Rv2677c-3/4 3.54 probable protoporphyrindogen oxidase 
Rv2682c(dxs1) Rv2682c-1/6 8.10 probable 1-deoxy-d-xylulose 5-phosphate 
 synthase  
BT-ppgK&sigA  3.20 tn>rv2703 : bt-ppgk&siga 
Rv2727c(miaA) Rv2727c-2/2 6.08 probable trna delta(2) 
-isopentenylpyrophosphate transferase  
Rv2841c(nusA) Rv2841c-2/3 3.38 probable n utilization protein a  
Rv2903c(lepB) Rv2903c-3/3 3.36 probable signal peptidase i  
Rv2948c(fadD22) Rv2948c-2/6 3.42 probable fatty-acid-coa ligase  
Rv2969c Rv2969c-1/2 15.70 possible conserved membrane  
Rv3003c(ilvB1) Rv3003c-1/5 3.65 probable acetolactate synthase   
Rv3005c Rv3005c-1/2 4.27 conserved hypothetical protein 
Rv3005c-2/2 4.25 
Rv3051c(nrdE) Rv3051c-3/6 6.08 ribonucleoside-di-p reductase 
Rv3091 Rv3091-2/5 4.41 conserved hypothetical protein 
Rv3222c Rv3222c-1/1 4.53 conserved hypothetical protein 
Rv3311 Rv3311-1/3 3.33 conserved hypothetical protein 
Rv3388(PE_PGRS52) Rv3388-6/7 7.25 pe-pgrs family protein 
Rv3394c Rv3394c-1/4 3.01 conserved hypothetical protein 
Rv3494c(mce4F) Rv3494c-4/5 7.77 mce-family protein  
Rv3624c(hpt) Rv3624c-1/2 3.57 hypoxanthine-guanine 
phosphoribosyltransferase  
BT-Rv3660c&Rv3661  5.70 rv3660c<tn>rv3661 : bt-rv3660c&rv3661 
Rv3667(acs) Rv3667-2/6 3.77 acetyl-coenzyme a synthetase  
Rv3667-3/6 17.69 
Rv3667-5/6 4.10 
Rv3703c Rv3703c-2/4 9.15 conserved hypothetical protein 
Rv3710(leuA) Rv3710-4/6 3.12 2-isopropylmalate synthase  
Rv3723 Rv3723-1/2 4.54 conserved transmembrane protein 
Rv3728 Rv3728-5/9 3.57 probable conserved membrane protein 
Rv3752c Rv3752c-1/2 39.72 possible cytidine/deoxycytidylate deaminase 
Rv3860 Rv3860-4/4 17.18 conserved hypothetical protein 
Rv3865 Rv3865-1/1 67.73 conserved hypothetical protein 
Rv3913(trxB2) Rv3913-2/3 3.26 probable thioredoxin reductase 
List of genes that are over-represented by TraSH analysis in the stearic acid rescue 
screen.  All genes have >3 fold over representation in the pool of stearic acid and 
propionate screen condition with a P-value <0.05.  
 
 
 
 
102 
 
Table 3.5 Under represented mutants only in palmitic acid TraSH 
Gene probe-ID Fold Function 
Rv0791c Rv0791c-1/3 -8.17 conserved hypothetical protein 
atsD Rv0663-5/7 -6.66 possible arylsulfatase atsd  
Rv0161 Rv0161-4/4 -6.39 possible oxidoreductase 
alkA Rv1317c-1/5 -5.48 probable ada regulatory protein alka  
gabD2 Rv1731-3/4 -5.20 succinate-semialdehyde dehydrogenase 
pbpA Rv0016c-4/4 -5.18 probable penicillin-binding protein pbpa 
Rv1813c Rv1813c-1/1 -5.07 conserved hypothetical protein 
bglS Rv0186-2/6 -4.97 probable beta-glucosidase bgls  
Rv1501 Rv1501-2/3 -4.89 conserved hypothetical protein 
dacB1 Rv3330-2/3 -4.77 probable penicillin-binding protein dacb1  
Rv1730c Rv1730c-1/5 -4.73 possible penicillin-binding protein 
Rv1366 Rv1366-2/2 -4.51 hypothetical protein 
Rv0988 Rv0988-2/3 -4.49 possible conserved exported protein 
Rv1823 Rv1823-2/3 -4.47 conserved hypothetical protein 
pip Rv0840c-2/3 -4.45 probable proline iminopeptidase pip  
Rv2095c Rv2095c-3/3 -4.43 conserved hypothetical protein 
Rv0141c Rv0141c-1/2 -4.30 hypothetical protein 
Rv2949c Rv2949c-2/2 -4.28 conserved hypothetical protein 
Rv0100 Rv0100-1/1 -4.26 conserved hypothetical protein 
Rv1771 Rv1771-1/3 -4.18 l-gulono-1,4-lactone dehydrogenase 
devR Rv3133c-2/2 -4.14 two component transcriptional regulator  
Rv0127 Rv0127-4/4 -4.02 conserved hypothetical protein 
List of genes that are under-represented by TraSH analysis in the stearic acid rescue screen. 
All genes have >4 fold under representation in the pool of stearic acid and propionate screen 
condition with a P-value <0.01. 
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Table 3.6 Over representors only in palmitic acid TraSH 
Synonym probe-ID Fold Function  
dxs1 Rv2682c-1/6 81.93 p1-deoxy-d-xylulose 5-phosphate synthase  
folB Rv3607c-1/1 41.22 probable dihydroneopterin aldolase  
fadE24 Rv3139-3/4 39.90 probable acyl-coa dehydrogenase  
Rv1856c Rv1856c-2/2 36.55 possible oxidoreductase 
Rv3055 Rv3055-1/1 32.11 possible transcriptional regulator  
Rv1444c Rv1444c-2/2 30.48 hypothetical protein 
icd1 Rv3339c-3/4 27.21 probable isocitrate dehydrogenase  
hycD Rv0084-1/3 26.69 possible formate hydrogenlyase hycd  
Rv2603c Rv2603c-1/2 25.25 highly conserved hypothetical protein 
asd Rv3708c-2/3 20.76 aspartate-semialdehyde dehydrogenase  
efpA Rv2846c-2/5 20.55 possible integral membrane efflux protein  
pks12 
 
 
 
 
Rv2048c-6/36 19.61 probable polyketide synthase pks12 
Rv2048c-12/36 8.21 
Rv2048c-27/36 7.98 
Rv2048c-26/36 3.90 
Rv2048c-1/36 3.27 
yrbE1A Rv0167-1/2 19.08 conserved integral membrane protein  
dfp Rv1391-3/4 17.84 flavoprotein homolog dfp 
Rv2305 Rv2305-4/4 17.50 hypothetical protein 
hemL Rv0524-3/4 16.39 glutamate-1-semialdehyde 2,1-aminomutase  
mce4A Rv3499c-2/3 16.06 mce-family protein mce4a 
echA7 Rv0971c-2/3 15.43 probable enoyl-coa hydratase echa7  
Rv3015c Rv3015c-1/3 15.33 conserved hypothetical protein 
Rv0452 Rv0452-1/3 13.71 possible transcriptional regulator 
Rv1125 Rv1125-3/4 13.25 conserved hypothetical protein 
Rv2747 Rv2747-2/2 13.24 gcn5-related n-acetyltransferase 
sodA Rv3846-1/2 13.09 superoxide dismutase]  
Rv0897c Rv0897c-1/5 13.00 probable oxidoreductase 
mycP5 Rv1796-1/5 12.92 probable membrane-anchored mycosin  
Rv3603c Rv3603c-1/3 12.20 conserved ala and leu rich protein 
Rv2060 Rv2060-2/2 12.19 conserved integral membrane protein 
Rv0064 Rv0064-8/8 12.14 conserved transmembrane protein 
Rv1779c Rv1779c-2/5 12.06 hypothetical integral membrane protein 
cyp126 Rv0778-3/4 11.91 possible cytochrome p450 126 cyp126 
bpoA Rv3473c-2/2 11.80 possible peroxidase  
Rv2413c Rv2413c-1/3 11.59 conserved hypothetical protein 
pckA Rv0211-4/5 11.46 phosphoenolpyruvate carboxykinase  
PPE6 Rv0305c-8/8 11.24 ppe family protein 
Rv2778c Rv2778c-1/1 10.75 conserved hypothetical protein 
mce2D Rv0592-5/5 10.52 mce-family protein mce2d 
List of genes that are under-represented by TraSH analysis in the stearic acid rescue 
screen. All genes have >10 fold under representation in the pool of stearic acid and 
propionate screen condition with a P-value <0.01. 
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Table 3.7 Under representors only in acetate TraSH 
List of genes that are over-represented by TraSH analysis in the stearic acid rescue 
screen.  All genes have >4 fold over representation in the pool of stearic acid and 
propionate screen condition with a P-value <0.01.  
 
 
 
 
 
 
 
 
 
 
 
 
Synonym probe-ID Fold  Function  
Rv3083 Rv3083-4/5 -9.04 probable monooxygenase  
Rv1639c Rv1639c-2/4 -7.38 conserved hypothetical membrane protein 
fadD31 Rv1925-3/5 -7.12 probable acyl-coa ligase  
mutT2 Rv1160-2/2 -6.99 probable mutator protein mutt  
Rv2568c Rv2568c-3/3 -6.54 conserved hypothetical protein 
Rv2716 Rv2716-1/2 -6.30 conserved hypothetical protein 
Rv0110 Rv0110-2/2 -6.27 conserved integral membrane protein 
Rv2030c Rv2030c-3/5 -6.20 conserved hypothetical protein 
lprJ Rv1690-2/2 -6.07 probable lipoprotein  
menC Rv0553-3/3 -5.42 probable muconate cycloisomerase  
fadE34 Rv3573c-2/6 -5.17 probable acyl-coa dehydrogenase  
Rv3228 Rv3228-2/3 -5.00 conserved hypothetical protein 
Rv3161c Rv3161c-2/3 -4.96 possible dioxygenase 
Rv1998c Rv1998c-1/2 -4.72 conserved hypothetical protein 
Rv3727 Rv3727-5/5 -4.67 possible oxidoreductase 
Rv1957 Rv1957-1/1 -4.65 hypothetical protein 
Rv1496 Rv1496-1/3 -4.56 possible transport system kinase 
moeB2 Rv3116-3/4 -4.26 molybdenum cofactor biosynthesis protein  
Rv2751 Rv2751-1/2 -4.22 conserved hypothetical protein 
Rv1112 Rv1112-3/3 -4.17 probable gtp binding protein 
Rv0919 Rv0919-2/2 -4.16 gcn5-related n-acetyltransferase 
PE31 Rv3477-1/1 -4.10 pe family protein 
mshB Rv1170-2/2 -4.07 glcnac-ins deacetylase 
Rv3114 Rv3114-1/1 -4.06 conserved hypothetical protein 
cyp139 Rv1666c-1/4 -4.02 probable cytochrome p450 139 
Rv0195 Rv0195-1/2 -4.02 possible two component transcriptional regulator 
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Table 3.8 Over representors only in acetate TraSH 
Synonym probe-ID Fold  Function 
Rv2015c Rv2015c-1/3 22.30 conserved hypothetical protein 
Rv1371 Rv1371-1/4 14.22 probable conserved membrane protein 
narX Rv1736c-5/5 12.66 probable nitrate reductase narx 
Rv2186c Rv2186c-1/1 11.99 conserved hypothetical protein 
katG Rv1908c-2/7 9.60 catalase-peroxidase-peroxynitritase t katg 
Rv1819c Rv1819c-5/6 7.42 probable atp-binding protein abc transporter 
lldD1 Rv0694-3/4 6.73 possible l-lactate dehydrogenase  
senX3 Rv0490-2/3 6.50 putative two component sensor histidine kinase  
Rv0998 Rv0998-3/3 5.84 conserved hypothetical protein 
Rv2978c Rv2978c-4/4 5.33 probable transposase 
lppH Rv3576-2/2 5.28 possible conserved lipoprotein lpph 
Rv2030c Rv2030c-4/5 4.76 conserved hypothetical protein 
cysQ Rv2131c-3/3 4.55 possible monophosphatase cysq 
Rv3629c Rv3629c-2/3 4.43 conserved integral membrane protein 
Rv0688 Rv0688-3/3 4.10 putative ferredoxin reductase 
Rv0955 Rv0955-4/4 3.92 conserved integral membrane protein 
PE_PGRS22 Rv1091-7/7 3.71 pe-pgrs family protein 
tgs1 Rv3130c-3/4 3.64 Triacylglycerol synthase  
Rv0906 Rv0906-2/3 3.48 conserved hypothetical protein 
Rv3134c Rv3134c-1/3 3.45 conserved hypothetical protein 
Rv0431 Rv0431-1/1 3.44 putative tuberculin related peptide 
lgt Rv1614-4/4 3.36 possible prolipoprotein diacylglyceryl transferases  
PPE60 Rv3478-2/4 3.27 pe family protein 
Rv2910c Rv2910c-2/2 3.17 conserved hypothetical protein 
Rv0540 Rv0540-1/2 3.07 conserved hypothetical protein 
List of genes that are over-represented by TraSH analysis in the stearic acid rescue 
screen.  All genes have >3 fold over representation in the pool of stearic acid and 
propionate screen condition with a P-value <0.01. Genes listed in red are related to 
propionate metabolism.  
 
 
 
 
 
106 
 
3. 5 References  
1. Peyron, P., et al., Foamy macrophages from tuberculous patients' granulomas 
constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS 
Pathog, 2008. 4(11): p. e1000204. 
2. Schnappinger, D., et al., Transcriptional Adaptation of Mycobacterium 
tuberculosis within Macrophages: Insights into the Phagosomal Environment. 
J Exp Med, 2003. 198(5): p. 693-704. 
3. Sacchettini, J.C., E.J. Rubin, and J.S. Freundlich, Drugs versus bugs: in 
pursuit of the persistent predator Mycobacterium tuberculosis. Nat Rev 
Microbiol, 2008. 6(1): p. 41-52. 
4. Koul, A., et al., The challenge of new drug discovery for tuberculosis. Nature, 
2011. 469(7331): p. 483-90. 
5. Marrero, J., et al., Gluconeogenic carbon flow of tricarboxylic acid cycle 
intermediates is critical for Mycobacterium tuberculosis to establish and 
maintain infection. Proc Natl Acad Sci U S A, 2010. 107(21): p. 9819-24. 
6. McKinney, J.D., et al., Persistence of Mycobacterium tuberculosis in 
macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. 
Nature, 2000. 406(6797): p. 735-8. 
7. Russell, D.G., C.E. Barry, 3rd, and J.L. Flynn, Tuberculosis: what we don't 
know can, and does, hurt us. Science, 2010. 328(5980): p. 852-6. 
8. Shi, L., et al., Carbon flux rerouting during Mycobacterium tuberculosis 
growth arrest. Mol Microbiol, 2010. 78(5): p. 1199-215. 
107 
 
9. Rohde, K.H., R.B. Abramovitch, and D.G. Russell, Mycobacterium 
tuberculosis invasion of macrophages: linking bacterial gene expression to 
environmental cues. Cell Host Microbe, 2007. 2(5): p. 352-64. 
10. Rohde, K.H., et al., Linking the transcriptional profiles and the physiological 
states of Mycobacterium tuberculosis during an extended intracellular 
infection. PLoS Pathog, 2012. 8(6): p. e1002769. 
11. Wilson, M., et al., Exploring drug-induced alterations in gene expression in 
Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sci 
U S A, 1999. 96(22): p. 12833-8. 
12. Sassetti, C. and E.J. Rubin, Genomic analyses of microbial virulence. Curr 
Opin Microbiol, 2002. 5(1): p. 27-32. 
13. van Opijnen, T. and A. Camilli, Transposon insertion sequencing: a new tool 
for systems-level analysis of microorganisms. Nat Rev Microbiol, 2013. 11(7): 
p. 435-42. 
14. Mei, J.M., et al., Identification of Staphylococcus aureus virulence genes in a 
murine model of bacteraemia using signature-tagged mutagenesis. Mol 
Microbiol, 1997. 26(2): p. 399-407. 
15. Griffin, J.E., et al., High-resolution phenotypic profiling defines genes 
essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog, 
2011. 7(9): p. e1002251. 
16. Sassetti, C.M., D.H. Boyd, and E.J. Rubin, Comprehensive identification of 
conditionally essential genes in mycobacteria. Proc Natl Acad Sci U S A, 2001. 
98(22): p. 12712-7. 
108 
 
17. Sassetti, C.M., D.H. Boyd, and E.J. Rubin, Genes required for mycobacterial 
growth defined by high density mutagenesis. Mol Microbiol, 2003. 48(1): p. 
77-84. 
18. Sassetti, C.M. and E.J. Rubin, Genetic requirements for mycobacterial survival 
during infection. Proc Natl Acad Sci U S A, 2003. 100(22): p. 12989-94. 
19. Kim, M.J., et al., Caseation of human tuberculosis granulomas correlates with 
elevated host lipid metabolism. EMBO Mol Med, 2010. 2(7): p. 258-74. 
20. Rousseau, C., et al., Virulence attenuation of two Mas-like polyketide synthase 
mutants of Mycobacterium tuberculosis. Microbiology, 2003. 149(Pt 7): p. 
1837-47. 
21. Abramovitch, R.B., et al., aprABC: a Mycobacterium tuberculosis complex-
specific locus that modulates pH-driven adaptation to the macrophage 
phagosome. Mol Microbiol, 2011. 80(3): p. 678-94. 
22. Gonzalo-Asensio, J., et al., PhoP: a missing piece in the intricate puzzle of 
Mycobacterium tuberculosis virulence. PLoS One, 2008. 3(10): p. e3496. 
23. Rocco, C.J. and J.C. Escalante-Semerena, In Salmonella enterica, 2-
methylcitrate blocks gluconeogenesis. J Bacteriol, 2010. 192(3): p. 771-8. 
24. Venugopal, A., et al., Virulence of Mycobacterium tuberculosis depends on 
lipoamide dehydrogenase, a member of three multienzyme complexes. Cell 
Host Microbe, 2011. 9(1): p. 21-31. 
25. Cole, S.T., et al., Deciphering the biology of Mycobacterium tuberculosis from 
the complete genome sequence. Nature, 1998. 393(6685): p. 537-44. 
109 
 
26. Krithika, R., et al., A genetic locus required for iron acquisition in 
Mycobacterium tuberculosis. Proc Natl Acad Sci U S A, 2006. 103(7): p. 
2069-74. 
27. Maloney, E., et al., Alterations in phospholipid catabolism in Mycobacterium 
tuberculosis lysX mutant. Front Microbiol, 2011. 2: p. 19. 
28. Bhatt, A., et al., The Mycobacterium tuberculosis FAS-II condensing enzymes: 
their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in 
future drug development. Mol Microbiol, 2007. 64(6): p. 1442-54. 
29. Minnikin, D.E., et al., The methyl-branched fortifications of Mycobacterium 
tuberculosis. Chem Biol, 2002. 9(5): p. 545-53. 
 
 
110 
 
CHAPTER FOUR  
Using the lipid droplet-loaded macrophages to elucidate propionyl-CoA 
assimilation during intracellular infection 
 
 
 
 
 
 
 
 
Adapted from 
Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit 
metabolic stress. Lee W, VanderVen BC, Fahey RJ, Russell DG. J Biol Chem. 2013 
Mar 8; 288(10):6788-800 
Infection of macrophages with Mycobacterium tuberculosis induces global 
modifications to phagosomal function. Podinovskaia M, Lee W, Caldwell S, Russell 
DG. Cell Microbiol. 2013 Jun; 15(6):843-59.  
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ABSTRACT 
 M. tuberculosis infection leads to the alternation of host lipid metabolism, and in the 
macrophage, one key change is the induction of foam cell formation by retention of 
fatty acids in intracellular lipid bodies. This lipid-rich host cell likely provides a 
privileged environment for M. tuberculosis and facilitates acquisition of fatty acids by 
the bacterium. In this work, we demonstrate that the induction of oleate-containing 
lipid droplets in macrophages rescued the growth of an M. tuberculosis Δicl1 mutant. 
Metabolic labeling of macrophages with radioactive fatty acids revealed that M. 
tuberculosis inside the oleate loaded macrophage exploits fatty acids derived from 
host to synthesize the cell wall lipids of the bacterium. Monitoring the lipid droplet we 
observed the metabolic interplay between the host cells and M. tuberculosis whereby 
mycobacterial infection causes retention of lipid droplets in infected versus uninfected 
macrophages. These data provide further confirmation that a significant stress from 
propionyl-CoA for M. tuberculosis inside host cells can be relieved by the routing of 
propionyl-CoA into the cell wall lipids of the bacterium, and suggests that a balanced 
lipid diet from the host cell is important to intracellular fitness and growth of M. 
tuberculosis.  
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4.1 Introduction 
Macrophages filled with lipid bodies, called foamy macrophages, are found in 
granulomas in human patients as well as macrophage infection in culture, and the tight 
interplay between Mycobacterium tuberculosis and the foamy macrophage has been 
noted previously [1-4]. Recent studies showed the tight apposition of the M. 
tuberculosis-containing phagosome to the lipid bodies [5]. This suggests that M. 
tuberculosis has access to host lipids, in the form of lipid bodies. Moreover, it has 
been shown that utilization of the triacylglycerol from the foamy macrophage resulted 
in up-regulation of genes associated with dormancy, and that this re-programing 
allowed intracellular M. tuberculosis to develop resistance against antibiotics such as 
isoniazid and rifampicin [6]. 
          Therefore, foamy macrophages provide a nutrient reservoir and play important 
roles in growth and persistence of M. tuberculosis in the host. The accumulation or 
sequestration of host lipids and their utilization by M. tuberculosis is part of the 
metabolic re-programing of the host cell that has been documented both in cell culture 
models and in human tuberculosis granulomas [5-8].   
          M. tuberculosis mutants defective in cholesterol utilization or in the expression 
of ICL1 exhibit reduced survival in macrophages and mice, and this defect is 
exacerbated further by activation of the host macrophages or the development of an 
effective immune response [9-11]. The similarity in phenotype between M. 
tuberculosis mutants defective in cholesterol utilization and mutants defective in 
expression of ICL1 is intriguing because it could result from related metabolic defects. 
M. tuberculosis mutants defective in utilization of cholesterol will starve if dependent 
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on the sterol as a carbon source, whereas mutants defective in ICL1 expression will be 
vulnerable to propionate toxicity should they metabolize cholesterol.   
          In Chapters 2 and 3, we showed that long chain fatty acids rescued the icl 
mutant from propionyl-CoA toxicity by facilitating methyl-branched lipid synthesis in 
vitro culture. Recently, Daniel and colleagues reported that intracellular M. 
tuberculosis can access and metabolize fatty acids from lipid droplet stores in their 
host cell [6].  This key observation suggests that it is feasible to establish whether or 
not M. tuberculosis experiences propionyl-CoA toxicity under the physiological 
conditions within its host cell and whether the bacterium manipulates the host lipid 
stores to provide metabolic rescue. 
          In this current study we manipulated the formation of lipid bodies in 
macrophages to elucidate the metabolic shift in M. tuberculosis in response to host-
lipid derived stresses. We demonstrate that M. tuberculosis faces a significant amount 
of propionyl-CoA during macrophage infection, and that through biochemical rescue, 
M. tuberculosis can access and metabolize the lipid stores in its host cell to shunt 
propionyl-CoA through favored, non-intoxicating routes of degradation or synthesis. 
Moreover, we demonstrate the tight interplay between the lipid metabolism of both 
host and pathogen during tuberculosis infection. Consistent with this result is the 
finding in the earlier chapters (Chapter 2 and 3). Our results provide mechanistic 
insights that the pathways of lipid degradation and cell wall synthesis play a critical 
role in the modulation of the relative levels of 3-carbon intermediates, propionyl-CoA 
and that this regulation is critical to the survival of intracellular M. tuberculosis.  
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4.2 MATERIAL and METHODS 
Bacterial strains and culture conditions 
M. tuberculosis and M. bovis strains were maintained in Middlebrook 7H9 medium 
supplemented with 0.2% glycerol, 10% OADC and 0.05% tyloxapol. Kanamycin (20 
g/ml) or hygromycin (50 g/ml) were used where necessary. All chemicals were 
purchased from Sigma unless otherwise stated. 
 
Mutant Strains 
To quantify survival of M. tuberculosis and M. bovis strains in macrophage infection 
experiments we transformed the relevant H37Rv and BCG strains with pVV16-
smyc’::mCherry expressing the fluorescent protein mCherry driven by the smyc 
promoter [12]. 
 
Metabolic Labeling and Lipid Analysis 
Metabolic radiolabeling of mycobacterial cell wall lipids were performed as described 
[12]. For intracellular labeling, lipid droplets were induced in macrophages (2x10
8
) by 
addition of 400 M oleate and 20 Ci of [1-14C] oleic acid, 20Ci [1 14C] stearic acid, 
or [1-
14
C] sodium propionate for 24 hours as described.  The cells were washed and 
infected either icl1 or Erdman (MOI=10:1) for 4 hours at 37°C. After 4 days, 
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macrophages were washed and harvested in PBS. Lipids from intracellular M. 
tuberculosis lipids were isolated as detailed by Singh et al [13] whereby infected 
macrophages were washed twice with PBS, followed by methanol wash to remove 
lipids derived from macrophage. Mycobacterial lipids were then extracted with 
CHCl3/CH3OH (2:1 v/v) for 48 hrs. The organic phase was collected, washed twice 
with water and dried (Folch wash). The total lipids were resuspended in 
CHCl3/CH3OH (2:1 v/v), and 
14
C incorporation was determined by a Scintillation 
Counter.   
 
TLC analysis 
To analyze lipid species we used 100, 000 counts per minute of the sample at TLC 
plates (10cm x 10cm silica gel 60 aluminum sheets). The TLC was developed with 
petroleum ether: ethyl acetate (98:2, v/v) solvent system, and followed by exposing to 
a phosphor screen and scanning by using a Storm Imager to detect and quantify the 
radiolabeled lipids.  
 
Lipid Droplet Induction and Macrophage Infection 
C57BL/6 mouse bone marrow-derived macrophages were cultured in DMEM 
containing 15% L929-conditioned medium, 10% fetal bovine serum, and 2 mM 
glutamate for 7 days. Lipid droplet induction was preformed as described [14]. Briefly, 
400 M oleate, conjugated to de-fatted BSA (1:5), was added to the macrophage 
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medium. To monitor lipid droplet formation, these macrophages were transferred to 24 
wells containing sterile cover slips and incubated up to 5 days in the presence of 400 
M oleate.  
          To assess the impact of lipid droplet formation on the survival of the Δicl1 
mutant, lipid droplets were induced in macrophages by incubation with 400 M oleate 
for 24 hrs prior to infecting the cells with icl1 (MOI=10) for 4 hours at 37°C.  The 
cultures were washed extensively and the intracellular bacterial load was assessed over 
a period of 8-9 days.  The bacterial load was quantified either by lysing the 
macrophages, plating the lysate on Middlebook 7H10 medium supplemented with 0.2% 
glycerol, 10% OADC, and counting cfus.  Or, alternatively, the infection was 
performed in 96 well plates at comparable MOI with Δicl1 (smyc`::mCherry), and the 
mCherry fluorescence was measured by a Perkin-Elmer EnVision plate reader over a 
period of 9 days.  Cultures were manipulated through the addition of Vitamin B12 to 
50 g/ml and maintained throughout the infection. 
 
Confocal microscopy 
Macrophages were washed with PBS twice and fixed with 4% parpformaldehyde in 
PBS for 30min at room temperature, followed by staining with a 1g/ml BODIPY 
493/503 (Invitrogen) dissolved in 150mM NaCl. After 10min incubation at room 
temperature, cells were washed with PBS twice and mounted in ProLong Gold 
Antifade Reagent (Molecular Probes). Images were obtained by using Leica TCS SP5 
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Confocal laser scanning microscople (Leica Microsystem) using 63 x oil immersion 
lens.  
 
4.3 RESULTS and DISCUSSION 
4.3.1 Intracellular M. tuberculosis can exploit host lipid stores to alleviate 
propionate-mediated stress.   
To determine the physiological significance of propionyl-CoA toxicity during 
infection, we induced lipid droplet formation in macrophages through the addition of 
400 M oleate to the culture medium  [14]. The resultant lipid droplets, detected by 
BODIPY 493/503, saturated within 1 day of culture (Figure 4.1). These macrophages, 
and control, untreated macrophages were subsequently infected with the Δicl1 mutant 
(containing smyc’::mCherry) (MOI=10), and bacterial growth was monitored in 
parallel by both CFU counts and by the fluorescent signal from mCherry.  As reported 
previously, the growth of the Δicl1 mutant was severely impaired in the control, 
untreated macrophages (Figure 4. 2).   
          In contrast, growth of the Δicl1 mutant was rescued in the macrophages 
preloaded with lipid droplets induced by addition of oleate.  Moreover, the addition of 
VitB12, which opens the methylmalonyl pathway of propionyl-CoA processing, to the 
culture medium was also capable of restoring intracellular growth to the Δicl1 mutant.   
The trends were comparable in both the CFU and the fluorescence readouts (Figure 
4.2), although the CFU count likely under-estimates bacterial viability due to  
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Figure 4.1 Lipid droplet induction in macrophage by addition of oleate. Figure 
illustrates the induction and persistence of lipids droplets, detected with BODIPY 
493/503 (green), Δicl1 strain expressing pVV16-mCherry (smyc`::mCherry) (red), and 
nuclei (blue) in oleate-loaded macrophages versus untreated macrophages over the 
duration of the experimental period.    
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Figure 4.2 Intracellular growth is restored to the Δicl1 mutant through the 
induction of oleate-containing lipid droplets in the infected cell. The survival of the 
Δicl1 mutant was seriously impaired in macrophages, however, growth could be 
restored through loading the host cells with oleate, or through the addition of VitB12 
to the medium to facilitate operation of the MMP. (A) The CFUs were determined at 2 
day intervals for an 8-day period for the Δicl1 mutant in untreated, control 
macrophages (triangle), in lipid droplet-containing, oleate-loaded macrophages (circle), 
and in macrophage supplemented by the addition of VitB12 to the medium (square). 
Results are representative of three replicates. (B) The experiment was repeated with an 
Δicl1 strain expressing pVV16-mCherry (smyc`::mCherry) and bacterial survival and 
growth was determined by measurement of fluorescence. Both methods demonstrated 
the enhanced growth and survival of the Δicl1 mutant in the presence of either oleate-
induced droplets or Exogenous VitB12.  Error bars indicate standard error of the mean 
from 3 replicates.   
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stress inflicted during bacterial isolation, while the fluorescence readout probably 
over-estimates viability due to persistent signal from dying bacteria. 
 
4.3.2 Metabolic labeling of macrophage 
          In order to demonstrate the incorporation of host-derived fatty acids into PDIM, 
we metabolically labeled macrophage lipid droplets with 
14
C-propionate, 
14
C-oleate, 
and 
14
C-stearic acid prior to infection with M. tuberculosis. Subsequent analysis of M. 
tuberculosis cell wall lipids post-infection revealed that 
14
C label from the 
14
C-
propionate, 
14
C-oleate, and 
14
C-stearic acid was incorporated into PDIM (Figure 4.3) 
providing biochemical confirmation of the intracellular growth phenotype shown in 
Figure 3.  These data confirm and extend three issues that are critical to our 
understanding of the physiology of M. tuberculosis within its host macrophage.  First, 
propionyl-CoA metabolism, and the relative balance of 2- and 3-carbon intermediates 
is a significant problem for M. tuberculosis within the environment of the host 
macrophage.  Second, the routing of propionyl-CoA through MM-CoA and into MB 
cell wall lipids such as PDIM is an important detoxification pathway to intracellular M. 
tuberculosis.  And, finally, the balance of lipids in the lipid droplets in the host 
macrophage may have considerable bearing on the fitness and growth potential of the 
bacterium within its host cell.   
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Figure 4.3. M. tuberculosis inside lipid droplet-loaded macrophage incorporates 
the host-derived fatty acids into PDIM. Using radio-labeled fatty acid precursors, 
we demonstrate the incorporation of the fatty acids and propionate into PDIM species 
in both the wt Erdman (A) and the Δicl1 mutant (B) strains.  Lipid droplets were 
induced in macrophages with oleic acid containing [1-
14
C] oleic acid (lane 1), [1-
14
C] 
stearic acid (lane 2), or [1-
14
C] propionate (lane 3) for 24 hours. Then, the lipid-loaded 
macrophages were infected with either Erdman or H37Rv Δicl1 at a MOI of 5:1 for 4 
hours. At 5 day post infection, M. tuberculosis cell wall lipids were extracted from 
macrophage and analyzed on TLC. The bands labeled correspond to (1) triacylglycerol, 
(2) phthiocerol A dimycocerate and (3) phthiodiolone dimycocerate. The identity of 
the PDIM bands had been established previously by mass spectrometry [12]. Control 
labeling experiments were run with M. tuberculosis Erdman grown in broth culture 
labeled with [1-
14
C] propionate (lane 4) and macrophages alone labeled with [1-
14
C] 
oleic acid (lane 5).  
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4.3.3 M. tuberculosis infection leads to retention of lipids and the maintenance of 
foamy macrophage phenotype 
As noted, lipid droplets in the macrophage also can be induced by infection, by 
hypoxia, or by feeding high concentration of lipid [6, 15]. Our data suggests that M. 
tuberculosis can exploit the host droplet to relieve metabolic stresses. Then, it is 
intriguing to consider whether or not the formation of lipid droplet is consequence of 
decreased turnover of lipids in the infected macrophage. To test this possibility, we 
decided to monitor lipid droplet retention in macrophage upon M. tuberculosis 
infection. Macrophages were preincubated in macrophage media supplemented with 
400 μM oleate conjugated in BSA for 24 h. Subsequently, the macrophages loaded 
with lipid droplets were infected with either M. tuberculosis CDC1551 or M. bovis 
expressing mcherry protein at multiplicity of infection (moi) of 10:1, or incubated 
without infection. Lipid droplets in macrophages were monitored by treatment with 
the BODIPY 493/503 prior to imaging by confocal microscope over several days. As 
observed in Figure 4.4, there was a significant increase in retention of lipid droplet in 
the macrophages infected M. tuberculosis. A marginal retention of the lipid was 
observed in the infection with M. bovis, comparable to that of infection with M. 
tuberculosis. In contrast, uninfected macrophages showed rapid lost of the lipid 
droplets within 48hrs. 
 
125 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
A 
126 
 
Figure 4.4 M. tuberculosis infection leads to retention of the foamy macrophage 
phenotype and facilitates bacterial access to host-derived lipids. Murine bone 
marrow-derived macrophages were induced to form foam cells through incubation 
with 400 μM oleate for 24 h. The cells were subsequently infected with M. 
tuberculosis, M. bovis, or left uninfected. (A) At 0 h and 48 h after infection (t=0 and 
t=48) cells were fixed and stained with BODIPY 493/503. (B) Retention of lipid 
bodies by M. tuberculosis was compared with that of M. bovis. M. tuberculosis and M. 
bovis are displayed in red, BODIPY 493/503 is displayed in green and DAPI-stained 
nuclei are shown in blue. Absence of green stain in uninfected cells at 48 h indicates 
loss of oleate-induced lipid droplets. 
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It is unclear if this retention represents a decreased degradation of the droplets through 
a reduction of phagosomal lipolysis or an increased trafficking of the droplets into the 
endosome. Nonetheless, these data are significant because such reprogramming in host 
lipid metabolism may provide a privileged niche for the bacterium in acquisition of 
nutrients [3, 5, 7, 16]. As noted, M. tuberculosis can exploit host lipids to synthesis 
virulence-associated polyketides, and as a carbon source for growth following 
reactivation [6, 9, 11, 17]. Moreover, M. tuberculosis containing lipid droplets have 
been postulated to represent a dormant non-replicative stage, which is innately 
resistant to antibiotics [6]. However, much of this host-pathogen metabolic crosstalk 
during infection remains to be elucidated.    
 
4.4 Concluding remarks 
          In macrophage infection, M. tuberculosis can access and exploit host lipids in 
forms of fatty acids from lipid droplets to provide acyl-primers required for the 
biosynthesis of methyl-branched polyketides. This is significant because the metabolic 
re-programming that we demonstrated through fatty acid-mediated rescue from 
propionate toxicity in in vitro culture also has validity within a macrophage infection 
model. These data also suggest that the tight control of the propionyl-CoA pool is 
critical to growth and persistence of the intracellular M. tuberculosis, and that lipid 
droplets serve as a well-balanced diet for M. tuberculosis because they contain a lipid 
mixture that providew balanced levels of acetyl-CoA and propionyl-CoA. Moreover, 
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lipid droplet retention in macrophages by M. tuberculosis infection provides insight 
into the metabolic interplay between the host cell and the intercellular bacterium.  
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CHAPTER FIVE 
Final discussion 
 
          Bacterial infection involves multiple adaptations to the host environments, and 
these processes play critical roles in mediating the host/pathogen interactions. Such 
activities include modification of the phagosomal compartments of the host cells, and 
modulation of the host immune responses. Metabolic realignment of the pathogen in 
response to the host environment is also an essential adaptation for intracellular 
survival. In the M. tuberculosis infection, in order to persist and replicate in the host 
cells, the bacterium has adapted its metabolism to the host-derived nutrients and 
physical conditions, and coordinated its metabolic status with its life cycle. As 
demonstrated by the requirement of the isocitrate lyase (ICL1) and PhoPR of M. 
tuberculosis for intracellular survival and in vivo infection, it has abilities to sense its 
environment and respond by modulating its cellular processes such as carbon 
metabolism, cell wall integrity, and energy metabolism.  
          A large and growing body of literature has emerged on metabolic reprogramming 
of M. tuberculosis during infection and this information is now being applied to define 
the major intracellular nutrients and the mycobacterial catabolic pathways required to 
metabolize them. It is well recognized that fatty acids derived from host lipids are 
dominant and important carbon sources for M. tuberculosis during infection, and most 
of these studies have been devoted to understanding how acquires and processes the 
nutrients. Relatively little is known regarding the realignment of the metabolic 
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pathways of M. tuberculosis to reduce metabolic stress during utilization of the host 
lipids.  However, it has been shown that Mycobacterium tuberculosis’ metabolic 
flexibility allows for increased capacity to survive in host cells. This discussion will 
reiterate those aspects of the modulation of the carbon flow associated with the 
utilization of host lipids, and will emphasize those observations made over the course 
of this study that may serve to guide future research into the coupled metabolism of 
host and pathogen.  
 
5.1 Metabolic stress during infection 
          As discussed in chapter 2, M. tuberculosis is sensitive to increases in propionyl-
CoA, which is a major product of cholesterol catabolism and the bacterium has three 
pathways to metabolize this intermediate [1, 2]. To verify that a functional 
methylcitrate cycle is essential for alleviating the increased propionyl-CoA pool, the 
growth of icl mutant was monitored in medium with alternative carbon sources.   
Whereas the growth of wild type H37Rv in medium with glycerol and glucose was 
unimpaired by the addition of propionate, the growth of the ICL1 mutant was inhibited 
strongly in the same conditions, suggesting that MCC function to detoxify propionyl-
CoA rather than to utilize propionate as a carbon source. Data from carbon 
supplementation of propionate-containing medium revealed that acetate rescued the 
propionate toxicity. Additionally, pyruvate was shown to rapidly accumulate upon 
propionate treatment. These data suggest that propionyl-CoA or its intermediates 
inhibited pyruvate dehydrogenase as reported in response to propionate by Aspergillus 
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[3] in contrast to Salmonella [4, 5]. Together, these observations demonstrate that, 
despite of absence of a functional MCC, propionate toxicity can be relieved by 
balancing between 3-carbon (propionyl-CoA) and 2-carbon (Acetyl-CoA) units.  
Moreover, long chain fatty acids (C4-C24) were shown to rescue propionate toxicity, 
implying that acetyl-CoA was consumed during detoxification of propionate. 
Metabolic labeling with 
14
C-propionate revealed the molecular mechanism for fatty 
acids rescue from the propionate toxicity. The fatty acids added to the medium 
functioned as primers for methyl-branched polyketides (such as PDIM), which 
enabled the bacterium to incorporate excess propionate into the polyketides. M. 
tuberculosis was shown to incorporate long chain fatty acid (stearic acid) into PDIM 
without catabolic -oxidation confirming that the fatty acids were utilized as primers 
and not through degradation and expansion of the acetyl-CoA pool. Together, these 
findings demonstrate that M. tuberculosis PDIM is an important “sink” for the 
detoxification of propionate, and that the balance between propionyl-CoA and acyl-
primers is critical to activate or sustain the flux of propionyl-CoA into PDIM.  
          As discussed in Chapter 3, the genetic profiling of propionate and stearic acid 
metabolism by TraSH verified these interpretations. Analysis of the output pool 
revealed both positive and negative selection of mutants involved in relieving or 
intensifying propionate-mediated toxicity. The biosynthesis of methyl-branched lipids 
appears to be required to relieve propionyl-CoA toxicity: PDIM, SL-1, PAT, and DAT. 
Additionally, in the MCC, the accumulation of all three intermediates, propionyl-CoA, 
2-methylcitrate, and 2-methylisocitrate were shown to be toxic to M. tuberculosis, 
which is consistent with observations for propionate toxicity in  Salmonella enterica 
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and Aspergillus nidulans[4, 5]. Although we found that one key to propionate toxicity 
seems to be an inhibition of PDH by propionyl-CoA, perhaps, 2-methylcitrate and 2-
methylisocitrate could be toxic to M. tuberculosis as shown in a Salmonella model 
where these intermediates inhibit fructose 1,6 bisphosphatase (FBP). However, as 
shown in Figure 2. 3, glucose was unable to rescue icl mutant from propionate 
toxicity suggesting that these intermediate of MCC are unlikely to inhibit any enzymes 
involved in gluconeogenesis including FBP. Alternatively, these toxic intermediates 
may inhibit one of three components of PDH complex. Additionally, the TraSH data 
revealed both known genes and novel pathways that control propionate metabolism 
and generation of acyl-primers for the synthesis of mycobacterial lipids. Moreover, 
mutants of a transcriptional regulator, PhoP were shown to be enriched in the selection, 
which further validates our model because a phoP mutant was shown to exhibit 
enhanced production of PDIM [6, 7]. Lastly, the TraSH data also identified a regulator, 
Rv1626, which may involve in a coordinated interplay between the MCC, MMP, and 
methyl-branched lipid synthesis.  
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Figure 5.1 The model of assimilation of host lipids and fatty acids into methyl-
branched M. tuberculosis virulence Lipids. M. tuberculosis has access to both 
cholesterol and fatty acids from the intracellular stores of its host macrophage.  
Degradation of cholesterol expands the propionyl-CoA pool, which is thought 
deleterious to the generation of acetyl-CoA from pyruvate through the activity of PDH.  
This places more pressure on the acetyl-CoA pool, which may be utilized for the 
generation of malonyl-CoA primers used in the assembly of M. tuberculosis cell wall 
lipids.  These MB cell wall lipids can be built from primers generated from either 
acetyl-CoA or from pre-formed long chain fatty acids imported by the bacterium.  The 
balance of these 2- and 3-carbon intermediates is clearly critical to the growth of M. 
tuberculosis, and its success within its host cell environment.  
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          As discussed in chapter 4, this metabolic process to relieve the propionate stress 
was also observed in M. tuberculosis infected in macrophages loaded with lipid 
droplets. Metabolic labeling with 
14
C fatty acids demonstrated that intercellular M. 
tuberculosis can access and utilize fatty acids from lipid droplets of macrophage, and 
that fatty acids from the lipid droplet likely serve as acyl-primers to facilitate synthesis 
of methyl branched polyketide (PDIM). These data suggest that our model for 
metabolic realignment to limit propionate toxicity is also valid in a host cell infection 
model (Figure 5.1).  
          M. tuberculosis is a metabolically-flexible bacterium [8-10]. This ability is 
believed to contribute to its extraordinary success, allowing it to persist and replicate 
within the host environment[9]. Current work focuses on the metabolic plasticity of M. 
tuberculosis by studying how the bacterium re-routes its carbon flow to adapt host 
nutrients. Our conclusion that M. tuberculosis has abilities to exploit host-derived fatty 
acids to limit metabolic stress from propionate toxicity was based on several lines of 
evidences. First, in in vitro culture, propionyl-CoA, a product of cholesterol, leads 
metabolic stress and this can be relieved by gating the synthesis of methyl-branched 
lipids (such as PDIM) through provision of acyl-primers. Secondly, in a macrophage 
infection model, M. tuberculosis is exposed in a significant stress derived from 
propionyl-CoA, and this metabolic stress can be alleviated through the induction of a 
foamy macrophage where the bacterium accesses and utilizes the host fatty acids to 
facilitate incorporation of propionyl-CoA into PDIM.   
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5.2 Ongoing experiments and future directions 
5.2.1. Fatty acids transporters  
          Our finding that fatty acids rescue the icl mutant from propionate toxicity 
brings up several questions to be addressed in future studies. For example, 
observations such as this could be applied to a forward genetic screen to identify 
mutants defective in the uptake and processing of short and long chain fatty acids. As 
discussed earlier, it has been believed that host lipids are critical to the survival of M. 
tuberculosis during infection [9, 11-13]. However, the fatty acids uptake and 
metabolic processing still remain to be elucidated. As detailed in Chapter 3, the screen 
that exploited the propionate toxicity identified several genes that may involve in 
stearic acid processing and uptake. In addition, mutants defective in survival in this 
screen (under-represented) may be more susceptible to stearic acid because, as shown 
in Chapter 2, similar to other saturated fatty acids, stearic acid also appeared to have a 
growth inhibitory effect. Indeed, most of under-represented genes that have been 
followed appear to be involved in susceptibility to stearic acid rather than its 
utilization (data not shown).  
          In order to precisely define the genes that are required for the stearic acid uptake 
and metabolic processing, we designed another TraSH-based screen to reveal mutants 
that were incapable of utilizing stearic acid, but were also resistant to its growth 
inhibition.  For this screen, we constructed a 10
5
 CFU library in CDC1551 using the 
mariner transposon as shown in Chapter 3.  
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Figure 5.2 TraSH screen for defining genes for stearic acid utilization. S and SG 
represent TraSH screen on stearic acid, and stearic acid plus glycerol, respectively. All 
genes selected were >3x-fold over-represented or >3x-fold under-represented with P-
values < 0.05. Significant genes in the subset of the second quadrant (upper left) are 
provided in Table 5.1  
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List of genes that have >3 fold under representation in the pool of stearic acid condition 
 but not under-represented in stearic acid and glycerol condition with a P-value <0.05.  
  
Table 5.1 Under representors in TraSH screen for stearic acid utilization  
Gene Function 
Stearic acid 
& glycerol 
TraSH 
Stearic acid 
TraSH 
Rv1242  conserved hypothetical protein  1.71 -10.7 
Rv2411c  conserved hypothetical protein  2.06 -9.27 
Rv1156  conserved hypothetical protein  3.08 -6.59 
Rv3401 hypothetical protein 1.35 -6.58 
Rv1099c  conserved hypothetical protein  1.86 -5.65 
Rv2097c  conserved hypothetical protein  1.46 -5.31 
Rv0794c  probable oxidoreductase  4.17 -5.22 
Rv1151c  probable transcriptional regulator 1.77 -4.76 
Rv0163  conserved hypothetical protein  2.93 -4.7 
Rv2459  probable integral membrane transporter 1.41 -4.62 
Rv2339 probable conserved transmembrane transporter  1.71 -4.58 
Rv0150c  conserved hypothetical protein 2.21 -4.02 
Rv2525c  conserved hypothetical protein 3.14 -3.89 
Rv3239c  probable conserved transmembrane transporter 1.33 -3.84 
Rv1072  probable conserved transmembrane protein 1.91 -3.42 
Rv1249c  probable transmembrane protein 3.32 -3.42 
Rv2953  conserved hypothetical protein  2.55 -3.38 
Rv3123  hypothetical protein  3.1 -3.34 
Rv2517c conserved hypothetical protein. 1.73 -3.3 
Rv0918  conserved hypothetical protein  1.55 -3.2 
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This library was grown in minimal medium containing 10mM glycerol (input pool) 
versus minimal medium containing stearic acid (output pool for stearic acid utilization: 
S) or strearic acid and 10mM glycerol (output pool for growth inhibition of stearic 
acid: SG). To identify genes that only impact the utilization of stearic acid, we 
compared the input and output pools of mutants to quantify the mutations that were 
under-represented or over-represented. As shown Figure 5.2, the TraSH analysis 
revealed that the under (or over) -representors from S screen were largely shared with 
those from SG, suggesting that the most dominant themes to emerge from both S and 
SG screen are genes involved in growth inhibition of stearic acid. However, we found 
a subset of genes that were likely involved in stearic acid processing (Table 5.1), and 
currently we are following those genes for further characterization.   
 
5.2.2 Isocitrate dehydrogenase regulator, Rv2170 
          As discussed earlier, the metabolic flexibility of M. tuberculosis relies on the 
enzyme isocitrate lyase (ICL) [14-16]. Due to the dual role of ICL in the glyoxylate 
shunt and methylcitrate cycle in M. tuberculosis, a functional ICL is required for 
growth of the bacterium in propionate or fatty acids [17, 18]. Moreover, under hypoxic 
conditions ICL was shown to play an important role in production of succinate that 
was required for ATP generation [19]. As shown in other bacteria, isocitrate, the 
substrate of ICL, is the entry point into glyoxylate cycles, and its flow is known to be 
regulated by isocitrate dehydrogenase (ICD), which converts isocitrate to -
ketoglutarate in the TCA cycles [20]. Despite the critical importance of understanding 
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this metabolic node in M. tuberculosis, the regulatory mechanism(s) impacting the 
metabolic flux downstream of isocitrate remain to be elucidated. Like other bacteria 
[21, 22], M. tuberculosis is likely to modulate the isocitrate flow through regulation of 
ICD activity.  Therefore we are interested in identifying potential ICD suppressor(s) 
that repress ICD activity in the presence of fatty acids and facilitates carbon flow into 
the glyoxylate cycle. 
          We hypothesized that if the growth icl mutant on fatty acid was slowed or 
delayed by an ICD suppressor, then the mutation of such a hypothetical suppressor 
would allow the mutant to grow on the fatty acid medium. To identify potential 
regulators for ICD a library of 10
5
 transposon mutants generated in H37Rv icl was 
grown on minimal medium containing 0.05mM stearic acid. In this screen, we 
identified the GCN5-related N-acetyltransferase (Rv2170) as being positively selected 
for increased growth. We selected 36 colonies and 27 of which have transposon 
insertion in upstream of Rv2170. As key regulatory mechanism, protein acetylation 
has been known to modulate enzyme activity involved in metabolic pathways [23-25]. 
In mycobacteria, protein acetylation is known to control diverse metabolic enzymes 
including acetyl-CoA synthetase [26-28].  
          To validate Rv2170 as an ICD suppressor, we examined the phenotypes of the 
mutant, H37Rv icl Tn::Rv2170. As shown in Figure 5.3, the double mutant icl 
Tn::Rv2170 was able to grow in stearic acid-containing medium, while the growth of 
the parent icl mutant strain was delayed with a marked initial lag phase.   
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Figure 5.3 Mutation of Rv2170 allows icl mutant to grow on fatty acids without 
initial lag phase. The Δicl1 mutant strain exhibits long initial lag phase on fatty acids 
but growth can be restored by inactivation of Rv2170.  (A) TCA and glyoxylate cyles 
(B) and (C) Bacterial growth, measured by absorbance at 600 nm, was determined for 
H37Rv wt, icl , icl Tn::Rv2170 , icl Tn::Rv2170 / pVV16-Rv2170 strains grown 
in minimal media containing 10mM glycerol (B) or 0.05mM stearic acid (C) as 
primary carbon source.  
  
A 
C                                    
B                                    
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Figure 5.4 Rv2170 represses ICD1 activity through acetylation. (A) Rv2170 
protein acetylates ICD1 in M. tuberculosis lysate dependent manner by using [14C, C-
1] acetyl-CoA as substrate. M. tuberculosis lysate was prepared from wt H37Rv 
grown on acetate as sole carbon. The lysate was depleted of proteins by passage 
through 2kDa size exclusion column (LM Mtb lysate). Upper gel, Coommassie-
stained SDS-PAGE gel. Lower gel, phosphorimage of the upper gel. (B) ICD1 (0.5g) 
activity was suppressed by addition of Rv2170 (0.3g) in M. tuberculosis lysate (LM 
Mtb lysate) dependent manner in presence of 50M acetyl-CoA. ICD1 activity was 
monitored by measuring NADP reduction at 340nm.   
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          To study this regulatory mechanism further, we tested whether recombinant 
Rv2170 could acetylate ICD in vitro. To achieve this, M. tuberculosis ICD1 (Rv3339c) 
and ICD2 (Rv0066c) were purified to homogeneity and incubated with purified 
Rv2170 in the presence of [
14
C, 1-C]-Acetyl-CoA. Following the failure of initial 
experiments we included M. tuberculosis lysate because cofactors such as cyclic AMP 
may be required for protein acetylation [27]. A bacterial lysate was prepared from M. 
tuberculosis H37Rv culture grown on 10mM acetate. The lysate was depleted of 
proteins by passage through a size exclusion column (2 kDa). As shown Figure 5.4A, 
Rv2170 acetylated ICD1 in the presence of the bacterial lysate, suggesting that 
Rv2170, as a protein acetyltransferase, was dependent on cofactors. Next, we assessed 
whether this interaction through protein acetylation would impact ICD1 activity.  To 
do this, we measured ICD activity with or without Rv2170. The ICD activity was 
monitored by the generation of NADPH which is cofactor of the ICD reaction.  We 
also included the M. tuberculosis lysate. As shown in Figure 5.4B, the activity of 
ICD1 was suppressed in the presence of Rv2170 and the bacterial lysate, 
demonstrating that acetylation of ICD1 by Rv2170 leaded a reduction of ICD1 activity 
in M. tuberculosis lysate-dependent manner. These data provide biochemical 
verification of the phenotype of the double mutant, icl Tn::Rv2170. Currently, we are 
following the Rv2170 to further elucidate a regulatory mechanism for isocitrate flow 
in central carbon pathway by studying potential lysine residues of ICD1 targeted by 
Rv2170, and by identifying cofactors that may be involved in this acetylation reaction.           
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5.3 Concluding remarks  
          The result presented in this study has clarified some key issues that are critical to 
our understanding of a metabolic reprogramming in M. tuberculosis during the course 
of infection. Our data by using in vitro culture and macrophage infection model has 
established how M. tuberculosis limit propionate mediated metabolic stress. 
Additionally, the genetic profiling by TraSH in this work provides a comprehensive 
characterization of fatty acid and propionate metabolism in M. tuberculosis; transport 
into the bacterial cell, the degradation and conversion of the fatty acids into primary 
metabolites.  Lastly, the present work provides insights that extend our appreciation of 
carbon metabolism of M. tuberculosis within its host cell and to develop novel 
chemotherapeutic strategies.   
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